<PAGE>
As filed with the Securities and Exchange Commission on June 16, 1997
Registration No. 333-26457
================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
---------------------
AMENDMENT No. 3
To
FORM S-1
REGISTRATION STATEMENT
Under
THE SECURITIES ACT OF 1933
---------------------
inTEST Corporation
(Exact name of registrant as specified in its charter)
<TABLE>
<CAPTION>
<S> <C> <C>
Delaware 3825 22-2370659
(State or other jurisdiction of (Primary Standard Industrial (I.R.S. Employer
incorporation or organization) Classification Code No.) Identification No.)
</TABLE>
2 Pin Oak Lane, Cherry Hill, New Jersey 08003, (609) 424-6886
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)
ALYN R. HOLT ROBERT E. MATTHIESSEN
Chairman and Chief Executive Officer President and Chief Operating Officer
inTEST Corporation
2 Pin Oak Lane, Cherry Hill, New Jersey 08003, (609) 424-6886
(Name, address, including zip code, and telephone number, including area code,
of agent for service)
Copies to:
CHARLES C. ZALL, ESQ. BARRY M. ABELSON, ESQ.
Saul, Ewing, Remick & Saul Pepper, Hamilton & Scheetz LLP
3800 Centre Square West 3000 Two Logan Square
Philadelphia, Pennsylvania 19102 18th and Arch Streets
(215) 972-7777 Philadelphia, Pennsylvania 19103
(215) 981-4000
Approximate date of commencement of proposed sale to the public: As soon as
practicable after the effective date of this Registration Statement.
---------------------
If any of the securities being registered on this form are to be offered
on a delayed or continuous basis pursuant to Rule 415 under the Securities Act
of 1933, check the following box. / /
If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list the Securities Act registration statement number of earlier effective
registration statement for the same offering. / /
If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. / /
If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. / /
The Registrant hereby amends this Registration Statement on such date or
dates as may be necessary to delay its effective date until the Registrant
shall file a further amendment which specifically states that this Registration
Statement shall thereafter become effective in accordance with Section 8(a) of
the Securities Act of 1933 or until the Registration Statement shall become
effective on such date as the Commission, acting pursuant to Section 8(a), may
determine.
================================================================================
<PAGE>
Information contained herein is subject to completion or amendment. A
registration statement relating to these securities has been filed with the
Securities and Exchange Commission. These securities may not be sold nor may
offers to buy be accepted prior to the time the registration statement becomes
effective. This prospectus shall not constitute an offer to sell or the
solicitation of an offer to buy nor shall there be any sale of these securities
in any state in which such offer, solicitation or sale would be unlawful prior
to registration or qualification under the securities laws of any such state.
SUBJECT TO COMPLETION, DATED JUNE 16, 1997
2,275,000 Shares
[inTEST Logo]
Common Stock
----------------
Of the 2,275,000 shares of Common Stock offered hereby, 1,820,000 are
being sold by inTEST Corporation ("inTEST" or the "Company") and 455,000 shares
are being sold by certain stockholders of the Company (the "Selling
Stockholders"). The Company will not receive any of the proceeds from the sale
of shares by the Selling Stockholders. See "Principal and Selling
Stockholders."
Prior to the offering, there has been no public market for the Common
Stock of the Company. It is currently estimated that the initial public
offering price for the Common Stock will be between $7.50 and $9.00 per share.
See "Underwriting" for information relating to the factors to be considered in
determining the initial public offering price. The Company has applied to have
the Common Stock approved for quotation on the Nasdaq National Market under the
symbol "INTT."
----------------
Prospective investors should carefully consider "Risk Factors" beginning on
page 5.
----------------
THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND
EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION NOR HAS THE
SECURITIES AND EXCHANGE COMMISSION OR ANY STATE SECURITIES
COMMISSION PASSED UPON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY
REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
<TABLE>
<CAPTION>
=========================================================================================
Underwriting
Price to Discounts and Proceeds to Proceeds to
Public Commissions(1) Company(2) Selling Stockholders
- -----------------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
Per Share ...... $ $ $ $
- -----------------------------------------------------------------------------------------
Total(3) ...... $ $ $ $
=========================================================================================
</TABLE>
(1) The Company and the Selling Stockholders have agreed to indemnify the
Underwriters against certain liabilities, including certain liabilities
under the Securities Act of 1933, as amended. See "Underwriting."
(2) Before deducting estimated expenses of $655,000 payable by the Company.
(3) The Selling Stockholders have granted the Underwriters an option,
exercisable within 30 days after the date of this Prospectus, to purchase
up to 341,250 additional shares of Common Stock solely to cover
over-allotments. If this option is exercised in full, the total Price to
Public, Underwriting Discounts and Commissions and Proceeds to Selling
Stockholders will be $_____________, $____________ and $____________,
respectively. See "Underwriting."
----------------
The shares of Common Stock are offered by the several Underwriters named
herein subject to prior sale, receipt and acceptance by them and subject to
their right to reject orders in whole or in part. It is expected that the
delivery of the certificates for such shares will be made on or about ,
1997 at the office of Janney Montgomery Scott Inc., Philadelphia, Pennsylvania.
----------------
JANNEY MONTGOMERY SCOTT INC. NEEDHAM & COMPANY, INC.
The date of this Prospectus is _________, 1997
<PAGE>
[Picture of a test head in position to dock to a device handler, each equipped
with inTEXT docking hardware.]
[Picture of inTEXT docking hardware consisting of a docking plate with three
cams and interconnecting cables.]
[Drawings depicting a test head being moved in each of the six degrees of motion
freedom.]
[Picture of inTEXT in2 Test Head Positioner (manipulator) holding a test head
equipped with inTEST docking hardware.]
----------------
"inTEST," the Company's logo on the cover of this Prospectus and the "in2"
logo are registered trademarks of inTEST Corporation. This Prospectus also
contains trademarks of other companies.
IN CONNECTION WITH THIS OFFERING, THE UNDERWRITERS MAY OVER-ALLOT OR
EFFECT TRANSACTIONS WHICH STABILIZE OR MAINTAIN THE MARKET PRICE OF THE COMMON
STOCK OF THE COMPANY AT A LEVEL ABOVE THAT WHICH MIGHT OTHERWISE PREVAIL IN THE
OPEN MARKET. SUCH STABILIZING, IF COMMENCED, MAY BE DISCONTINUED AT ANY TIME.
2
<PAGE>
PROSPECTUS SUMMARY
The following summary is qualified in its entirety by the more detailed
information and Consolidated Financial Statements and Notes thereto appearing
elsewhere in this Prospectus. Unless the context otherwise requires, all
references herein to the "Company" or "inTEST" include inTEST Corporation
("inTEST CORP") and its subsidiaries. All information in this Prospectus
assumes no exercise of the Underwriters' over-allotment option and gives effect
to (i) a stock split in the form of a stock dividend in the amount of 0.5579
shares for every one share outstanding which was effected on June 4, 1997, (ii)
the termination of the Company's status as an S corporation immediately prior
to the offering and (iii) the issuance of an aggregate of 300,443 shares of
Common Stock simultaneously with the closing of the offering in exchange for
the minority interests in the Company's three foreign subsidiaries (the
"Exchange"). See "The Company" and "S Corporation Distributions."
The Company
The Company is a leading independent designer, manufacturer and marketer of
docking hardware and test head manipulators, which are used with automatic test
equipment ("ATE") by semiconductor manufacturers during the testing of wafers
and packaged devices. The Company believes it is a leader based upon its
knowledge and experience in the industry. The Company also designs and markets
related ATE interface products including high performance test sockets,
interface boards and probing assemblies. The Company's products are designed to
improve the utilization and cost-effectiveness of ATE (including testers, wafer
probers and device handlers) during the testing of linear, digital and mixed
signal integrated circuits. Since inception in 1981, the Company has developed
and continues to support over 4,600 products and has been granted 13 U.S.
patents for its technology.
Testing is an integral and necessary step during the design and
manufacture of wafers and packaged devices. Each integrated circuit is tested
at least twice during the manufacturing process to ensure the functional and
electrical performance of each circuit. The increasing worldwide demand for
semiconductors in recent years has led to an increase in the demand for ATE.
According to VLSI Research Inc., in 1996 semiconductor manufacturers spent an
estimated $3.7 billion on testers and $1.3 billion on wafer probers and device
handlers. The increasing complexity of wafers and packaged devices, as
manifested by larger wafers, higher speeds, growing pin counts, smaller
packaged devices and greater levels of integration has changed the design,
architecture and complexity of ATE used during the testing of such devices and
has resulted in an increased demand for the Company's products.
The Company's docking hardware products mechanically control the intimate
interface between the test head's interface board and the prober's probing
assembly or handler's test socket. Such docking hardware facilitates the quick,
easy and safe changeover of test heads to probers or handlers, thereby allowing
semiconductor manufacturers to achieve cost savings by (i) improving ATE
utilization, (ii) improving the accuracy and integrity of test results and
(iii) reducing the need to repair or replace expensive ATE interface products.
The Company's docking hardware can be designed to be used with substantially
all makes and models of test heads, probers and handlers, and can usually be
designed to allow all ATE on a test floor to be mechanically "plug-compatible."
The Company's in2 free-standing, floating-head universal manipulators are
designed to be used in either a dedicated or a flexible test environment and
have been engineered to hold test heads in an effectively weightless state, and
can be moved up or down, right or left, forward or backward and rotated around
each axis (six degrees of motion freedom). Consequently, an operator using no
more than 22 pounds of force can reposition a test head weighing up to
approximately 900 pounds by grasping it in his or her hands and gently moving
the test head into position to dock with a prober or handler.
The Company's largest customers include Lucent Technologies, Motorola, SGS
Thomson and Texas Instruments among semiconductor manufacturers, and Credence
Systems, LTX and Teradyne among ATE manufacturers. The Company designs, markets
and supports its products globally both through Company account managers based
in New Jersey, Texas, California, the U.K., Singapore and Japan and through
independent sales representatives in the U.S. and abroad. The Company's
executive offices are located in Cherry Hill, New Jersey. Manufacturing
facilities are located in New Jersey and the U.K.
3
<PAGE>
The Offering
<TABLE>
<S> <C>
Common Stock offered by the Company ............... 1,820,000 shares
Common Stock offered by the Selling Stockholders . 455,000 shares
Total offering .................................... 2,275,000 shares
Common Stock to be outstanding after the offering . 5,911,034 shares(1)
Use of Proceeds .................................... For working capital, general corporate
purposes (which may include S corpora-
tion distributions) and possible acquisi-
tions. See "Use of Proceeds."
Proposed Nasdaq National Market symbol ............ INTT
</TABLE>
Summary Consolidated Financial Information
(in thousands, except per share data)
<TABLE>
<CAPTION>
Three months ended
Years ended December 31, March 31,
---------------------------------------------------- -------------------
1992 1993 1994 1995 1996 1996 1997
--------- --------- --------- --------- -------- --------- --------
<S> <C> <C> <C> <C> <C> <C> <C>
Consolidated Statement of Earnings Data:
Revenues ............................................. $ 6,512 $ 8,875 $ 9,287 $14,442 $18,582 $ 6,089 $ 3,887
Gross profit .......................................... 3,254 5,415 5,510 9,251 11,827 4,233 2,285
Operating income ....................................... 649 1,767 1,289 4,037 5,616 2,694 1,007
Earnings before income taxes and minority interest ... $ 605 $ 1,782 $ 1,326 $ 4,070 $ 5,717 $ 2,706 $ 1,022
-------- -------- -------- -------- -------- -------- -------
Pro forma net earnings (2) ........................... $ 3,370 $ 538
Pro forma net earnings per share (2) .................. $ 0.82 $ 0.13
Pro forma weighted average shares outstanding (1)(2) ... 4,091 4,091
Supplemental pro forma net earnings per share (3) ...... $0.79 $0.13
Supplemental pro forma weighted average shares out-
standing (3) .......................................... 4,291 4,291
</TABLE>
<TABLE>
<CAPTION>
March 31, 1997
-----------------------------------------------
Pro forma
Actual Pro forma (4) as adjusted (4)(5)
--------- --------------- -------------------
<S> <C> <C> <C>
Consolidated Balance Sheet Data:
Cash and cash equivalents ...... $ 2,983 $ 2,983 $16,292
Working capital .................. 3,924 560 13,869
Total assets ..................... 7,492 9,056 22,365
Long term debt .................. 148 148 148
Total stockholders' equity ...... 4,154 2,581 15,890
</TABLE>
<PAGE>
- ------------
(1) Includes 300,443 shares of Common Stock to be issued in the Exchange, and
excludes 150,000 shares of Common Stock issuable upon the exercise of
stock options, the grant of which will become effective as of the
effective date of the Registration Statement of which this Prospectus is a
part (the "Registration Statement") and which will be exercisable at the
initial public offering price. None of such options will be exercisable
until one year after the effective date of grant. See "Management -- 1997
Stock Plan."
(2) Assumes the termination of the Company's S corporation status effective
January 1, 1996 and the completion of the Exchange on January 1, 1996, and
as a result reflects the amortization of goodwill associated therewith and
the absence of a charge for the minority interest. See Note 3 of Notes to
Consolidated Financial Statements.
(3) Supplemental pro forma net earnings per share reflects the assumed issuance
of 200,000 shares of Common Stock, based on an assumed initial public
offering price of $8.25 per share, to fund distributions to the Company's
current stockholders of previously taxed but undistributed S corporation
earnings, net of available cash and cash equivalents (estimated to be $1.7
million as of March 31, 1997). See "Use of Proceeds," "S Corporation
Distributions" and Note 3 of Notes to Consolidated Financial Statements.
(4) Reflects the acquisition of the minority interests in the Company's foreign
subsidiaries pursuant to the Exchange, including goodwill arising from the
Exchange, and the effects of the termination of the Company's S
corporation status, including the distribution described under "S
Corporation Distributions." See Note 3 of Notes to Consolidated Financial
Statements.
(5) Adjusted to reflect the sale by the Company of 1,820,000 shares of Common
Stock offered hereby at an assumed initial public offering price of $8.25
per share and the receipt of the estimated net proceeds therefrom (after
deducting estimated underwriting discounts and commissions and estimated
offering expenses payable by the Company). See "Use of Proceeds" and
"Capitalization."
4
<PAGE>
RISK FACTORS
An investment in the shares of Common Stock offered hereby involves a high
degree of risk. Prospective investors should carefully consider the following
risk factors in addition to the other information set forth in this Prospectus.
This Prospectus contains certain statements of a forward-looking nature
relating to future events or the future financial performance of the Company.
Prospective investors are cautioned that such statements are only predictions
and that actual events or results may differ materially.
Dependence upon Semiconductor Industry. The Company's business is
substantially dependent upon the level of activity and capital expenditures of
semiconductor manufacturers. The semiconductor industry is highly cyclical and
has from time to time experienced periods of excess capacity which often have
had a severely detrimental effect on the industry's demand for ATE. There can
be no assurance that the Company's business and results of operations will not
be materially adversely affected by downturns in the semiconductor industry
generally, or by downturns or changes in any one or more particular market
segments of the semiconductor industry in which the Company participates. See
"Management's Discussion and Analysis of Financial Condition and Results of
Operations."
Fluctuations in Revenues and Operating Results. The Company's revenues and
operating results have fluctuated and could in the future fluctuate
significantly from period to period, including from one quarterly period to
another, due to a combination of factors, including the cyclicality of the
semiconductor industry, delays in the Company's shipments of products, the mix
of products sold, the mix of customers and the regions of the world where sales
are made in a particular period, the level of the Company's fixed costs,
cancellation or rescheduling of orders by customers and competitive pricing
pressures. In the fourth quarter of 1996, for example, the Company experienced
an operating loss substantially as a result of reduced revenues. The Company
believes such reduced revenues reflect the reduction by semiconductor
manufacturers of commitments to purchase ATE products in the second and third
quarters of 1996. The impact of these and other factors on the Company's
revenues and operating results in any future period cannot be forecast with
accuracy. See "Management's Discussion and Analysis of Financial Condition and
Results of Operations."
Importance of Patents and Proprietary Rights; Risk of Litigation. The
Company's success depends in significant part on its ability to obtain patent
protection for its proprietary technologies and to preserve its trade secrets.
The Company's U.S. issued patents will expire at various times beginning in
2002 and extending through 2015. There can be no assurance that additional
patents will be issued on the Company's pending or future applications, or that
any patents now or hereafter owned by the Company will afford protection
against competitors that develop similar technology or products. There is no
certainty that any patents issued to the Company will be held valid if
subsequently challenged or subjected to reexamination or reissue, that others
will not claim rights in the patents and other proprietary technology owned by
the Company or that the Company's efforts to protect its proprietary rights
will be successful generally or in any specific circumstance. There are no
pending lawsuits or claims against the Company regarding infringement of any
existing patents or other intellectual property rights of others.
The Company has notified one of its competitors that the Company believes
the competitor's products infringe on one of the Company's U.S. patents. The
competitor responded by alleging that certain claims of the patent are invalid
based on an earlier issued U.S. patent. The Company, in order to strengthen its
patent position, requested reexamination of its patent by the U.S. Patent and
Trademark Office (the "PTO") over that earlier issued U.S. patent. The
competitor thereafter also requested a reexamination of the patent. A
reexamination provides the PTO with an opportunity to reevaluate the validity
of the claims of a patent previously issued by the PTO. On April 7, 1997, the
PTO issued an Office Action in Reexamination confirming five of the nine claims
of the Company's patent, and rejecting four claims. On April 29, 1997, the
Company's patent attorney presented to the Examiner in charge of the
Reexamination a minor amendment to the claims. In response, the Examiner agreed
that the proposed amendment appears to overcome the rejection of the four
claims. Based on advice of its patent counsel, the Company believes that upon
formal submission of the proposed amendment, all claims will be deemed
patentable and the Commissioner of the PTO will issue a Certificate of
Reexamination to that effect. Although there can be no assurance, the Company
believes that the failure of the PTO ultimately to deem patentable some or all
of the four claims rejected in the Office Action will not have a material
adverse effect on the Company's business or results of operations. See
"Business--Patents and Other Proprietary Rights."
5
<PAGE>
Competition. The ATE industry is highly competitive. Many of the Company's
competitors have greater financial resources and some have more extensive
engineering, manufacturing, marketing and customer support capabilities than
the Company. The Company's competitors include independent manufacturers of
docking hardware, manipulators and related ATE interface products, designers
and manufacturers of ATE and, to a lesser extent, semiconductor manufacturers'
in-house ATE interface groups. The independent manufacturers of docking
hardware and manipulators which compete with the Company include Reid-Ashman
Manufacturing of the U.S., Microhandling of Germany and Shang Sheng of Taiwan.
The manufacturers of ATE which compete with the Company in the sale of docking
hardware and manipulators include Credence Systems, LTX, Schlumberger and
Teradyne. The Company competes with numerous independent manufacturers of
related ATE interface products. The Company principally competes on the basis
of product performance and functionality, product reliability, customer
service, applications support, price and timely product delivery. There can be
no assurance that the Company's competitors will not develop competing products
that will offer performance features that are superior to the Company's
products. The Company believes that in order to remain competitive, it must
continue to commit a significant portion of its personnel, financial resources,
research and development and customer support in developing new products and in
maintaining customer satisfaction worldwide. See "Business -- Competition."
Importance of Product Development. The market for ATE is subject to rapid
technological change and new product introductions, as well as advancing
industry standards. The development of increasingly complex semiconductors and
the utilization of semiconductors in a broader spectrum of products have driven
the need for more advanced ATE systems to test such devices at an acceptable
cost. The demand for these new ATE systems provides both the opportunity and
the need for the Company to develop additional products. There can be no
assurance that the Company will be successful in developing, manufacturing or
selling new products, that the introduction of such products will coincide with
the development of new generations of semiconductors or that such products will
satisfy customer needs or achieve market acceptance. The failure to provide
customers with new products could have a material adverse effect on the
Company's business and results of operations, as well as its customer
relationships. See "Business -- Strategy" and " -- Products."
Acquisitions. Although the Company has not made an acquisition since 1985,
a key element of its growth strategy is to acquire businesses, technologies or
products that are complementary to those of the Company. There can be no
assurance that the Company will be able to acquire and integrate successfully
such businesses, technologies or products or that any financing which may be
necessary for such acquisitions can be obtained on favorable terms or at all.
Furthermore, the integration of an acquisition may cause a diversion of
management's time and resources. Acquisitions by the Company could result in
dilutive issuances of equity securities and additional debt and amortization
expenses related to goodwill and intangible assets. In addition, gross profit
margins of acquired products, necessary product or technology development
expenditures and other factors related to any such acquisition could result in
dilution to the Company's stockholders or have other material adverse effects
on the Company's business and results of operations. The Company is not
currently a party to any agreement or understanding with respect to any
acquisition. See "Business -- Strategy."
International Sales and Operations. Approximately 37% and 43% of the
Company's revenues were generated by the Company's three foreign subsidiaries,
and approximately 5% and 19% of the Company's revenues were derived from sales
by inTEST CORP to customers located outside the U.S., in the first quarter of
1997 and in 1996, respectively. The Company intends to expand its international
presence and expects that international revenues will continue to represent a
significant portion of its revenues. See "Business -- Strategy." Sales to
customers outside the U.S. and operations in foreign countries are subject to
risks in addition to those incident to domestic sales and operations, including
the imposition of financial and operational governmental controls and
regulatory restrictions, the need to comply with a wide variety of U.S. and
foreign import and export laws, political and economic instability, trade
restrictions, changes in tariffs and taxes, longer payment cycles and the
greater difficulty of administering business abroad. There can be no assurance
that any of these factors will not have a material adverse effect on the
Company's business or results of operations. A significant portion of the
Company's revenues is denominated in foreign currencies, and accordingly, the
Company's business and results of operations may be affected by fluctuations in
interest and currency exchange rates. Also, the laws of certain foreign
countries may not protect the Company's intellectual property to the same
extent as do the laws of the U.S. See "Business -- Markets and Customers" and
Note 4 of Notes to Consolidated Financial Statements.
6
<PAGE>
Customer Concentration. Although the Company's largest customers generally
change from year to year, sales to the Company's top ten customers accounted
for 70%, 73% and 69% of the Company's revenues in 1996, 1995 and 1994,
respectively, and sales to one customer, Lucent Technologies, accounted for
16%, 16% and 7% in 1996, 1995 and 1994, respectively. The Company sells to its
customers on a purchase order or other limited basis and not pursuant to long
term contracts. There can be no assurance that the Company will be able to
retain its largest customers or that such customers will not cancel or
reschedule orders. The loss of a major customer or a reduction in orders by
major customers, including reductions due to market or competitive conditions
in the semiconductor industry, could have a material adverse effect on the
Company's business and results of operations. See "Business -- Markets and
Customers."
Dependence on Key Suppliers. The Company relies on third party suppliers,
fabricators, finishers and manufacturers (collectively, "Suppliers") in the
production of its products. Although the Company believes that all raw
materials and component parts are currently available in adequate amounts,
there can be no assurance that shortages will not develop in the future.
Certain of the raw materials and component parts for the Company's docking
hardware and manipulator products are purchased from single Suppliers, and
certain of the Company's docking hardware and manipulator products are
fabricated by single fabricators and finished by single finishers. The related
ATE interface products sold by the Company are manufactured to the Company's
specifications by third party fabricators, finishers and manufacturers, and
certain of those products are purchased from single Suppliers. The Company does
not have written agreements with such Suppliers. Although the Company believes
there are alternative Suppliers for all such products, a termination or
significant disruption of any of its existing supplier arrangements could have
a material adverse effect on the Company's business and results of operations.
See "Business -- Manufacturing and Supply."
Dependence on Key Personnel. The loss of any one or more of the key
technical staff or managers of the Company could have a material adverse effect
on the Company's business and results of operations. Due to the importance of
long term relationships generally in Japan, the loss of any key employee of the
Company's Japanese subsidiary could have similar adverse consequences on the
Company's Japanese operations. From time to time, there is intense competition
for qualified employees among companies in the ATE industry, academic
institutions and other businesses. The Company does not have written employment
agreements with any of its executive officers or other key employees, nor does
the Company maintain key-person life insurance on any of its employees. There
can be no assurance that the Company will be successful in hiring or retaining
qualified personnel, and the inability to attract and motivate highly skilled
employees could have a material adverse effect on the Company's business and
results of operations. See "Business -- Strategy," " -- Employees" and
"Management."
Control by Principal Stockholders. Upon completion of the offering, the
Company's Chairman and Chief Executive Officer, Alyn R. Holt, and all of the
executive officers and directors of the Company, collectively, will
beneficially own approximately 31% and 50%, respectively, of the Common Stock
(28% and 45%, respectively, if the over-allotment option is exercised in full).
Existing management will hold sufficient voting power to enable it to continue
to exert significant influence over the business and affairs of the Company for
the foreseeable future. Such concentration of control of the Company may also
have the effect of discouraging bids for the Common Stock at a premium over the
market price and may have a material adverse effect on the market price of the
Common Stock. See "Principal and Selling Stockholders."
Broad Management Discretion as to Use of Proceeds. The net proceeds of the
offering will be used for working capital, general corporate purposes and
possible acquisitions of businesses, technologies or products complementary to
the Company's business. If the Company were to make any such acquisition, it
might use a significant portion of the net proceeds in connection with such
acquisition. The Company currently has no specific agreements or plans with
respect to such acquisitions, and there can be no assurance the Company will
consummate any acquisition. Accordingly, the Company's management will retain
broad discretion as to the allocation of a significant portion of the net
proceeds from the offering. See "Use of Proceeds" and "Business -- Strategy."
Anti-Takeover Protection. Certain provisions of the Company's Certificate
of Incorporation and of Delaware law could discourage potential acquisition
proposals and could delay or prevent a change in control of the Company. Such
provisions could diminish the opportunities for a stockholder to participate in
tender offers, including those at a premium over the market price of the Common
Stock. Such provisions may also inhibit
7
<PAGE>
increases in the market price of the Common Stock that could result from
takeover attempts. In addition, the Board of Directors is authorized, without
further stockholder approval, to issue up to 5,000,000 shares of Preferred
Stock. The issuance of some or all of such shares could have the effect of
delaying, deterring or preventing a change in control of the Company. The
issuance of Preferred Stock could also have a dilutive effect on stockholders'
equity and a material adverse effect on the voting power of the holders of
Common Stock, including the loss of voting control to others. The Company has
no present plans to issue any Preferred Stock. See "Description of Capital
Stock -- Preferred Stock" and " -- Certain Corporate Provisions."
No Prior Public Market; Possible Volatility of Stock Price;
Dilution. Prior to the offering, there has been no public market for the Common
Stock, and there can be no assurance that an active public market for the
Common Stock will develop or be sustained after the offering. The initial
public offering price was determined through negotiations between the Company
and the representatives of the Underwriters (the "Representatives") based on
several factors and may not be indicative of the market price of the Common
Stock after the offering. See "Underwriting." The trading price of the
Company's Common Stock could be subject to wide fluctuations in response to
quarterly variations in the Company's operating results, announcements of
technological innovations or new products by the Company or its competitors,
developments concerning patents or proprietary rights or other events or
factors. The stock market has experienced extreme price and volume fluctuations
which have particularly affected the market prices of many technology companies
and small capitalization stocks in particular, and which have often been
unrelated to the operating performance of these companies. These broad market
fluctuations, as well as general economic and political conditions, may have an
unfavorable effect on the market price of the Common Stock. Purchasers of the
Common Stock offered hereby will experience immediate and substantial dilution
in net tangible book value of the Common Stock. See " -- Anti-Takeover
Protection" and "Dilution."
Shares Eligible for Future Sale. The sale of a substantial number of
shares of Common Stock, or the perception that such sales could occur, could
have a material adverse effect on prevailing market prices for the Common
Stock. In addition, any such sale or such perception could make it more
difficult for the Company to sell equity securities or equity-related
securities in the future at a time and price that the Company deems
appropriate. Upon consummation of the offering, the Company will have a total
of 5,911,034 shares of Common Stock outstanding, of which the 2,275,000 shares
offered hereby will be eligible for immediate sale in the public market without
restriction, unless they are held by "affiliates" of the Company within the
meaning of Rule 144 under the Securities Act of 1933, as amended (the
"Securities Act"). The remaining 3,636,034 shares will be "restricted"
securities within the meaning of Rule 144 under the Securities Act and will be
eligible for public sale thereunder subject to volume limitations and other
conditions of Rule 144, if applicable. As of the date of this Prospectus, the
Company and the holders of all of its Common Stock have agreed that they will
not sell any shares of Common Stock or related securities of the Company
without the prior written consent of Janney Montgomery Scott Inc., for a period
of 180 days from the date of this Prospectus. Notwithstanding the foregoing,
Mr. Holt reserved the right to make a charitable contribution of up to 100,000
shares of Common Stock which would not be subject to the lock-up agreement.
Upon expiration of such 180 day period, 297,841 of the currently outstanding
restricted shares will be eligible for public sale under Rule 144 without any
volume or other limitations. No prediction can be made as to the effect, if
any, that future sales of Common Stock, or the availability of Common Stock for
future sale, will have on the market price of the Common Stock from time to
time or the Company's ability to raise capital through an offering of its
equity securities. In addition, the Company plans to file a registration
statement within 185 days of the date of this Prospectus to permit the sale of
up to 500,000 shares of Common Stock which may be issued to employees in the
future pursuant to the Company's 1997 Stock Plan. See "Management -- 1997 Stock
Plan" and "Shares Eligible for Future Sale."
8
<PAGE>
THE COMPANY
The Company was incorporated in New Jersey in 1981 and reincorporated in
Delaware in April 1997. The Company has three foreign subsidiaries: inTEST
Limited ("inTEST LTD"), a British corporation located in Thame, England, U.K.;
inTEST Kabushiki Kaisha ("inTEST KK"), a Japanese corporation located in
Kichijoji, Japan; and inTEST PTE, Limited ("inTEST PTE"), a Singapore
corporation located in Singapore. The Company maintains its headquarters at 2
Pin Oak Lane, Cherry Hill, New Jersey 08003. The Company's telephone number is
(609) 424-6886 and its Internet e-mail address is [email protected].
The Company and the minority stockholders of each of the Company's foreign
subsidiaries have agreed that simultaneous with the closing of the offering,
the Company will acquire the minority interests in each of the three foreign
subsidiaries by means of the Exchange, pursuant to which the Company will issue
shares of its Common Stock in exchange for the shares of stock of each foreign
subsidiary held by the minority stockholders. The agreed upon exchange ratio
for the minority interests is based on the average percentage contribution of
each subsidiary to the Company's consolidated earnings before interest and
taxes for the three most recent years. Such average percentage contribution to
the Company's consolidated earnings before interest and taxes for inTEST LTD,
inTEST KK and inTEST PTE was 20.5%, 12.0% and 2.5%, respectively. In connection
with the Exchange, the Company will issue 300,443 shares of Common Stock to the
minority stockholders of the foreign subsidiaries. These shares would have a
value of approximately $2.5 million assuming an initial public offering price
of $8.25 per share.
Alyn R. Holt, the Company's Chairman and Chief Executive Officer, will
receive a total of 48,487 shares of the Company's Common Stock in exchange for
his shares of stock in the foreign subsidiaries. Mr. Holt is the only director,
officer or stockholder of inTEST CORP who owns shares of common stock in any of
the foreign subsidiaries. Each of the minority stockholders of the foreign
subsidiaries, including Mr. Holt, will receive shares of the Company's Common
Stock based upon the same exchange ratio. See "Principal and Selling
Stockholders."
USE OF PROCEEDS
The proceeds to be received by the Company from the sale of the Common
Stock offered hereby (net of estimated underwriting discounts and commissions
and offering expenses) will be approximately $13.3 million, assuming an initial
public offering price of $8.25 per share. The Company will not receive any
proceeds from the sale of shares of Common Stock by the Selling Stockholders.
The Company does not have a specific budget for the application of the net
proceeds, which will be used for working capital, general corporate purposes
and possible acquisitions of businesses, technologies or products complementary
to the Company's business. A key element of the Company's growth strategy is to
seek to acquire businesses, technologies or products involving one or more of
the many ATE interface products related to its principal docking hardware and
manipulator product lines. If the Company were to make any such acquisition, it
might use a significant portion of the net proceeds or incur additional
indebtedness in connection with such acquisition. A major purpose of this
offering is to enable the Company to act upon acquisition opportunities by
providing cash as well as a form of marketable security that can be used to
fund one or more acquisitions. At the present time the Company is not engaged
in any negotiations with third parties and has no specific agreements or plans
with respect to such acquisitions, and there can be no assurance the Company
will consummate any acquisition. See "Risk Factors -- Broad Management
Discretion as to Use of Proceeds" and "Business -- Strategy."
Although there can be no assurance, the Company believes it will have,
exclusive of the net proceeds of the offering, cash and cash equivalents in
excess of the amount necessary to pay a final S corporation distribution to the
Company's current stockholders. To the extent the Company does not have
sufficient cash and cash equivalents to pay such distribution, the Company may
use a portion of the net proceeds to fund a portion of such distribution. If
the final S corporation distribution had been made on March 31, 1997, the
distribution would have exceeded the Company's available cash and cash
equivalents by approximately $1.7 million. See "S Corporation Distributions"
and Note 3 of Notes to Consolidated Financial Statements.
Pending use as set forth above, the Company intends to invest the proceeds
in investment-grade, short term, interest-bearing securities or shares of
investment companies investing primarily in such securities.
9
<PAGE>
S CORPORATION DISTRIBUTIONS
Prior to the offering, the Company has been a corporation subject to
taxation under Subchapter S of the Internal Revenue Code of 1986, as amended.
As a result, the net earnings of the Company have been taxed, for Federal and
certain New Jersey state income tax purposes, as income of the Company's
stockholders, and the Company periodically paid dividends to its stockholders
in amounts exceeding such stockholders' liabilities for taxes.
The Company will terminate its S corporation status prior to the sale of
the Common Stock offered hereby (the "Termination Date") and distribute to its
current stockholders a final amount representing the Company's previously taxed
but undistributed S corporation earnings through the Termination Date. The
amount of the final distribution would have been approximately $3.4 million if
the Termination Date had been March 31, 1997, but the amount distributed will
include the Company's actual taxable income through the Termination Date, less
distributions to stockholders during that time period. The Company intends to
make this distribution, in one or more installments, prior to December 31,
1997. Purchasers of shares of Common Stock in the offering will not receive any
portion of the S corporation distribution. The Company believes it will have,
exclusive of the net proceeds of the offering, cash and cash equivalents in
excess of the amount necessary to pay the final S corporation distribution
following the Termination Date. See "Use of Proceeds."
DIVIDEND POLICY
The Company does not anticipate paying cash dividends in the foreseeable
future, but intends to retain future earnings, if any, for reinvestment in the
operation and expansion of the Company's business. Any determination to pay
cash dividends will be at the discretion of the Board of Directors and will be
dependent upon the Company's financial condition, results of operations,
capital requirements and such other factors as the Board of Directors deems
relevant.
10
<PAGE>
CAPITALIZATION
The following table sets forth (i) the capitalization of the Company at
March 31, 1997, (ii) the pro forma capitalization at that date reflecting both
the issuance of an aggregate of 300,443 shares of Common Stock in the Exchange
and the termination of the Company's S corporation status and (iii) the
capitalization as adjusted at that date to give effect to the pro forma
adjustments described above, the sale of the 1,820,000 shares of Common Stock
offered by the Company hereby at an assumed initial public offering price of
$8.25 per share and the receipt of the estimated net proceeds therefrom. This
table should be read in conjunction with the Consolidated Financial Statements
and Notes thereto included elsewhere in this Prospectus.
<TABLE>
<CAPTION>
March 31, 1997
--------------------------------------
(in thousands)
Pro forma
Actual Pro forma as adjusted
--------- ----------- ------------
<S> <C> <C> <C>
Long term debt ................................................... $ 148 $ 148 $ 148
Minority interest ................................................ 291 -- --
-------- -------- -------
Stockholders' equity:
Preferred stock, $0.01 par value; 5,000,000 shares authorized; no
shares issued or outstanding .................................... -- -- --
Common stock, $0.01 par value; 20,000,000 shares authorized;
3,790,591 shares issued and outstanding actual, 4,091,034 shares
issued and outstanding pro forma and 5,911,034 shares issued and
outstanding pro forma as adjusted .............................. 38 41 59
Additional paid-in capital ....................................... 689 2,574 15,865
Retained earnings ................................................ 3,461 -- --
Foreign currency translation adjustment ........................ (34) (34) (34)
-------- -------- --------
Total stockholders' equity ....................................... 4,154 2,581 15,890
-------- -------- --------
Total capitalization ............................................. $ 4,593 $ 2,729 $ 16,038
======== ======== ========
</TABLE>
11
<PAGE>
DILUTION
At March 31, 1997, the pro forma net tangible book value of the Company
was $1,073,000 or $0.26 per share of Common Stock. Pro forma net tangible book
value per share represents total assets less intangible assets, less total
liabilities, divided by the number of shares of Common Stock outstanding at
that date after giving effect to the Exchange. After giving effect to the
receipt of the net proceeds from the sale of the 1,820,000 shares of Common
Stock offered by the Company hereby at an assumed initial public offering price
of $8.25 per share, and after deducting underwriting discounts and estimated
offering expenses, the pro forma net tangible book value as of March 31, 1997
would have been $14,382,000 or $2.43 per share of Common Stock. This represents
an immediate increase in net tangible book value of $2.17 per share to existing
stockholders and an immediate dilution of $5.82 per share to new investors
purchasing the shares of Common Stock offered hereby. The following table
illustrates this dilution on a per share basis:
<TABLE>
<S> <C> <C>
Assumed initial public offering price per share ..................... $ 8.25
Pro forma net tangible book value per share before the offering ... $ 0.26
Increase per share attributable to new investors .................. 2.17
-------
Pro forma net tangible book value per share after the offering ...... 2.43
-------
Dilution per share to new investors ................................. $ 5.82
=======
</TABLE>
The following table sets forth, as of March 31, 1997, and after giving
effect to the Exchange and the offering, the difference between existing
stockholders and new investors with respect to the number of shares of Common
Stock purchased from the Company (but not those purchased from the Selling
Stockholders), the total cash consideration paid and the average price per
share.
<TABLE>
<CAPTION>
Shares Purchased Cash Consideration Average
----------------------- ------------------------- Price
Number Percent Amount Percent Per Share
----------- --------- ------------- --------- ----------
<S> <C> <C> <C> <C> <C>
Existing stockholders ...... 4,091,034 69.2% $ 1,173,000 7.2% $0.29
New investors ............... 1,820,000 30.8 15,015,000 92.8 8.25
---------- ------- ------------ -------
Total(1) .................. 5,911,034 100.0% $16,188,000 100.0%
========== ======= ============ =======
</TABLE>
- ------------
(1) Sales by the Selling Stockholders in the offering will reduce the number of
shares held by existing stockholders to 3,636,034 or 61.5% of the total
number of shares of Common Stock outstanding after the offering (3,294,784
and 55.7% if the Underwriters' over-allotment option is exercised in
full), and will increase the number of shares held by new investors to
2,275,000 or 38.5% of the total number of shares of Common Stock
outstanding after the offering (2,616,250 and 44.3% if the Underwriters'
over-allotment is exercised in full).
12
<PAGE>
SELECTED CONSOLIDATED FINANCIAL DATA
The following table contains certain selected consolidated financial data
of the Company and is qualified by the more detailed Consolidated Financial
Statements and Notes thereto included elsewhere in this Prospectus. The
consolidated statement of earnings data for the years ended December 31, 1992,
1993, 1994, 1995 and 1996 and the consolidated balance sheet data as of
December 31, 1992, 1993, 1994, 1995 and 1996 have been derived from the
Consolidated Financial Statements of the Company which have been audited by
KPMG Peat Marwick LLP, independent certified public accountants, as indicated
in their report included elsewhere in this Prospectus. The consolidated
statement of earnings data for the three months ended March 31, 1996 and 1997
and the consolidated balance sheet data as of March 31, 1996 and 1997 are
derived from unaudited financial statements. The unaudited financial statements
include all adjustments (consisting only of normal recurring adjustments) that
the Company considers necessary for a fair presentation of the results of
operations for such periods. The following data should be read in conjunction
with "Management's Discussion and Analysis of Financial Condition and Results
of Operations" and the Consolidated Financial Statements and Notes thereto and
other financial information included elsewhere in this Prospectus.
<TABLE>
<CAPTION>
Three months ended
Years ended December 31, March 31,
------------------------------------------------------ ------------------
1992 1993 1994 1995 1996 1996 1997
--------- --------- --------- -------- ---------- --------- --------
(in thousands, except per share data)
<S> <C> <C> <C> <C> <C> <C> <C>
Consolidated Statement of Earnings Data:
Revenues ........................................... $ 6,512 $ 8,875 $ 9,287 $ 14,442 $ 18,582 $ 6,089 $ 3,887
Cost of revenues .................................. 3,258 3,460 3,777 5,191 6,755 1,856 1,602
-------- -------- -------- -------- -------- -------- --------
Gross profit ..................................... 3,254 5,415 5,510 9,251 11,827 4,233 2,285
Operating expenses:
Selling expense .................................. 1,027 1,466 1,491 2,118 2,471 781 493
Research and development expense ................ 750 953 1,623 1,930 1,928 394 374
General and administrative expense ................ 828 1,229 1,107 1,166 1,812 364 411
-------- -------- -------- -------- -------- -------- --------
Total operating expenses ......................... 2,605 3,648 4,221 5,214 6,211 1,539 1,278
-------- -------- -------- -------- -------- -------- --------
Operating income .................................. 649 1,767 1,289 4,037 5,616 2,694 1,007
Other income (expense):
Interest income .................................. 23 20 22 82 147 23 29
Interest expense .................................. (50) (40) (9) -- (11) (5) (4)
Other ........................................... (17) 35 24 (49) (35) (6) (10)
-------- -------- -------- -------- -------- -------- --------
Total other income (expense) ................... (44) 15 37 33 101 12 15
-------- -------- -------- -------- -------- -------- --------
Earnings before income taxes and minority interest . 605 1,782 1,326 4,070 5,717 2,706 1,022
Income tax expense ............................... 103 254 382 637 858 355 167
-------- -------- -------- -------- -------- -------- --------
Earnings before minority interest ................ 502 1,528 944 3,433 4,859 2,351 855
Minority interest .................................. (36) (64) (127) (181) (213) (94) (11)
-------- -------- -------- -------- -------- -------- --------
Net earnings ..................................... $ 466 $ 1,464 $ 817 $ 3,252 $ 4,646 $ 2,257 $ 844
======== ======== ======== ======== ======== ======== ========
Pro forma net earnings (1) ......................... $ 3,370 $ 538
Pro forma net earnings per share (1) ............. $ 0.82 $ 0.13
Pro forma weighted average shares outstanding (1) . 4,091 4,091
Supplemental pro forma net earnings per share (2) . $ 0.79 $ 0.13
Supplemental pro forma weighted average shares
outstanding (2) .................................. 4,291 4,291
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
December 31, March 31, 1997
--------------------------------------------------------- ----------------------
Pro
1992 1993 1994 1995 1996 Actual forma (3)
--------- --------- --------- --------- --------- --------- ----------
(in thousands)
<S> <C> <C> <C> <C> <C> <C> <C>
Consolidated Balance Sheet Data:
Cash and cash equivalents ...... $ 943 $ 1,034 $ 1,336 $ 1,919 $ 3,692 $ 2,983 $ 2,983
Working capital .................. 1,526 2,546 2,944 4,201 4,377 3,924 560
Total assets ..................... 2,976 3,675 4,624 6,352 7,716 7,492 9,056
Long term debt .................. -- -- -- -- 155 148 148
Total stockholders' equity ...... 1,436 2,448 2,765 4,048 4,587 4,154 2,581
</TABLE>
- ------------
(1) Assumes the termination of the Company's S corporation status effective
January 1, 1996 and the completion of the Exchange on January 1, 1996, and
as a result reflects the amortization of goodwill associated therewith and
the absence of a charge for the minority interest. See Note 3 of Notes to
Consolidated Financial Statements.
(2) Supplemental pro forma net earnings per share reflects the assumed issuance
of 200,000 shares of Common Stock, based on an assumed initial public
offering price of $8.25 per share, to fund distributions to the Company's
current stockholders of previously taxed but undistributed S corporation
earnings, net of available cash and cash equivalents (estimated to be $1.7
million as of March 31, 1997). See "Use of Proceeds," "S Corporation
Distributions" and Note 3 of Notes to Consolidated Financial Statements.
(3) Reflects the acquisition of the minority interests in the Company's foreign
subsidiaries pursuant to the Exchange, including goodwill arising from the
Exchange, and the effects of the termination of the Company's S
corporation status, including the distribution described under "S
Corporation Distributions." See Note 3 of Notes to Consolidated Financial
Statements.
13
<PAGE>
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Overview
The Company was founded in 1981 to design and develop docking hardware,
test head manipulators and related ATE interface products. In 1982, the Company
introduced its first docking hardware and the in2 test head manipulator. The
Company has designed more than 4,600 products since its inception, and believes
that its products have been purchased by most major semiconductor
manufacturers. A significant majority of the Company's revenues for the 15
months ended March 31, 1997 was derived from sales of its docking hardware and
manipulator products, and the remainder was derived from sales of related ATE
interface products.
The Company's revenues have fluctuated generally as a result of
cyclicality in the semiconductor manufacturing industry. The Company believes
that purchases of the Company's docking hardware and manipulators are typically
made from its customers' capital expenditure budgets, while related ATE
interface products, which must be replaced periodically, are typically made
from its customers' operating budgets. When semiconductor manufacturing
activity generally slowed during much of 1996, many semiconductor manufacturers
reduced their capital expenditure budgets and, correspondingly, postponed or
cancelled orders for ATE and related equipment. As a result, starting in the
second quarter of 1996 through the fourth quarter of 1996, the Company's orders
for and sales of docking hardware and manipulators declined substantially.
During this same period, orders for and sales of related ATE interface products
also declined, but to a lesser extent. Although the Company experienced
increased orders for and sales of all of its products in the first quarter of
1997 compared to the fourth quarter of 1996, the Company's revenues were
substantially below the record high revenues realized in the first quarter of
1996.
The Company sells to semiconductor manufacturers and ATE manufacturers
either through inTEST account managers or through independent sales
representatives. The mix of customers during any given period may affect the
Company's gross margin due to the difference in accounting for sales discounts
and commissions. Specifically, sales discounts, typical in sales by inTEST
account managers to ATE manufacturers worldwide, are a direct reduction of
revenue and have the effect of reducing gross margin. In contrast, trade
discounts offered on sales to semiconductor manufacturers, while also a
reduction in revenue, are generally lower than sales discounts to ATE
manufacturers and accordingly have less impact on gross margin. Additionally,
commissions paid to independent sales representatives on sales to semiconductor
manufacturers in North America and Southeast Asia are charged to selling
expense and do not affect gross margin. Consequently, the relative mix of
customers for the Company's products and the region of the world where sales
are made have affected and will affect the Company's gross margin and selling
expense. Operating income, however, has not been materially affected by the
foregoing factors, because commissions paid to independent sales
representatives plus trade discounts on sales to semiconductor manufacturers
are approximately equal to the sales discounts given on sales to ATE
manufacturers. See "Business -- Sales and Distribution."
The Company believes that the ultimate destination of a significant
majority of its products is outside the U.S. Approximately 37%, 43%, 49% and
54% of the Company's revenues for the three months ended March 31, 1997 and the
years ended December 31, 1996, 1995 and 1994, respectively, were derived from
sales by the Company's three foreign subsidiaries. Approximately 5%, 19%, 19%
and 6% of the Company's revenues for the three months ended March 31, 1997 and
the years ended December 31, 1996, 1995 and 1994, respectively, were derived
from sales by inTEST CORP which were shipped to customer locations outside the
U.S. Although the Company has exposure to foreign currency fluctuations as a
result of its foreign operations, it believes its exposure to foreign currency
fluctuations is not significant. Foreign currency transaction gains and losses
were ($31,000), ($43,000) and $25,000 in 1996, 1995 and 1994, respectively. The
minority interest shown in the Company's Consolidated Financial Statements
reflects the approximately 21% interest in each of the Company's three foreign
subsidiaries which are to be acquired upon the closing of the offering pursuant
to the Exchange.
Prior to the offering, the Company and its stockholders elected to be
treated as an S corporation for Federal and New Jersey state income tax
purposes. Accordingly, while the Company's Consolidated Financial Statements
reflect income tax expense related to its foreign operations and certain state
income taxes, they do not include a provision for Federal income tax expense.
In connection with the offering, the Company will terminate
14
<PAGE>
its S corporation status and will become subject to Federal and additional New
Jersey state income taxes in future years. Management anticipates that the
Company's prospective effective tax rate will approximate 40%, although this
rate could fluctuate from period-to-period depending on the mix of domestic and
foreign earnings, the availability of foreign tax credits and on other factors.
The Company will also begin to provide for deferred income taxes in future
periods, although no provision will be made for foreign earnings intended to be
permanently invested abroad, which approximate $1.0 million at March 31, 1997.
The Company believes the effect of such additional taxes on the Company's
liquidity will be more than offset by the elimination of the Company's
practice, as an S corporation, of distributing dividends to its stockholders.
Such dividends totaled 88%, 61% and 79% of the Company's net earnings in 1996,
1995 and 1994, respectively.
Results of Operations
The following table sets forth, for the periods indicated, the percentage
of the Company's revenues represented by certain line items of its Consolidated
Statements of Earnings:
<TABLE>
<CAPTION>
Three months ended
Years ended December 31, March 31,
--------------------------------- ----------------------
1994 1995 1996 1996 1997
--------- --------- --------- --------- ----------
<S> <C> <C> <C> <C> <C>
Revenues .......................................... 100.0% 100.0% 100.0% 100.0% 100.0%
Cost of revenues .................................... 40.7 35.9 36.4 30.5 41.2
------- ------- ------- ------- -------
Gross margin ....................................... 59.3 64.1 63.6 69.5 58.8
Operating expenses:
Selling expense .................................... 16.0 14.6 13.3 12.8 12.7
Research and development expense .................. 17.5 13.4 10.4 6.5 9.6
General and administrative expense ............... 11.9 8.1 9.7 6.0 10.6
------- ------- ------- ------- -------
Total operating expenses ........................ 45.4 36.1 33.4 25.3 32.9
------- ------- ------- ------- -------
Operating income .................................... 13.9 28.0 30.2 44.2 25.9
Other income ....................................... 0.4 0.2 0.5 0.2 0.4
------- ------- ------- ------- -------
Earnings before income taxes and minority interest . 14.3 28.2 30.7 44.4 26.3
Income tax expense ................................. 4.1 4.4 4.6 5.8 4.3
Minority interest ................................. (1.4) (1.3) (1.1) (1.5) (0.3)
------- ------- ------- ------- -------
Net earnings ....................................... 8.8% 22.5% 25.0% 37.1% 21.7%
======= ======= ======= ======= =======
</TABLE>
Three Months Ended March 31, 1997 Compared to Three Months Ended March 31, 1996
Revenues. Revenues were $3.9 million for the first quarter of 1997
compared to a record $6.1 million for the same period in 1996, a decrease of
$2.2 million or 36%. The substantial fluctuation in revenues followed the
cyclicality of the semiconductor industry during the same periods. Revenues for
the first quarter of 1996 reflected an increased level of capital expenditures
in the semiconductor industry, which was followed by a general decline in such
expenditures during much of the balance of 1996. Revenues for the first quarter
of 1997, although down from the first quarter of 1996, indicate an increase in
commitments for capital expenditures which began in the industry at the end of
1996. As a result, revenues for the first quarter of 1997 exceeded revenues for
the fourth quarter of 1996 by 46% or $1.2 million, and the Company's backlog
increased from $1.8 million at December 31, 1996 to $2.3 million at March 31,
1997.
Gross Margin. Gross margin declined to 59% for the first quarter of 1997
from 70% for the same period in 1996. The decrease was principally attributable
to the fact that sales to ATE manufacturers generated approximately one-third
of the Company's revenues in the first quarter of 1997 compared to
approximately one-fifth in the first quarter of 1996. The Company believes that
this shift in customer mix is not indicative of a trend. The reduced gross
margin also reflects higher incremental material costs, due to lower
manufacturing levels, and higher fixed costs (principally rent, depreciation
and salaries) for the first quarter of 1997 compared to the same period in
1996.
15
<PAGE>
Selling Expense. Selling expense was $0.5 million for the first quarter of
1997 compared to $0.8 million for the same period in 1996, a decrease of $0.3
million or 37%. The decrease was due principally to a decrease in commissions
and other variable expenses associated with lower sales activity, as well as a
lower percentage of revenues from commission sales to semiconductor
manufacturers.
Research and Development Expense. Research and development expense was
$0.4 million for the first quarter of both 1997 and 1996. The primary component
of research and development expense is compensation, which did not change
materially for the first quarter of 1997 compared to the same period in 1996.
Most of the Company's technical staff are engaged in both research and
development and sales functions.
General and Administrative Expense. General and administrative expense was
$0.4 million for the first quarter of both 1997 and 1996. The primary component
of general and administrative expense is compensation, which did not change
materially for the first quarter of 1997 compared to the same period in 1996.
Income Tax Expense. As an S corporation, net earnings are taxed as income
to the Company's stockholders for Federal income tax. However, income tax
expense includes certain state income taxes and taxes imposed by foreign
jurisdictions. Income tax expense decreased to $0.2 million for the first
quarter of 1997 from $0.4 million for the same period in 1996, a decrease of
$0.2 million or 53%, primarily as a result of reduced operating income on lower
revenues, offset by an increase in the Company's effective tax rate. The
Company's effective tax rate was 16% for the first quarter of 1997 compared to
13% for the same period in 1996. The increase in the effective tax rate was
caused primarily by a greater percentage of earnings before income taxes and
minority interest being attributable to the Company's foreign subsidiaries.
1996 Compared to 1995
Revenues. Revenues were $18.6 million for 1996 compared to $14.4 million
for 1995, an increase of $4.2 million or 29%. The increase was due to the
higher levels of shipments of the Company's products during the first nine
months of 1996, which were based on orders placed by semiconductor
manufacturers during late 1995 and early 1996. The Company did not increase
sales prices significantly in 1996. The Company believes that more than half of
the Company's increased revenues was from sales of products used in the testing
of mixed signal devices, and the balance was from sales of products used in the
testing of digital devices, such as microprocessors and microcontrollers, and
numerous other devices used in the automotive, computer, telecommunications and
other industries.
Gross Margin. Gross margin remained constant at 64% for both 1996 and
1995. The percentage of the Company's revenues derived from sales to ATE
manufacturers increased by 8% in 1996 compared to 1995, which had the effect of
reducing gross margin for 1996. The reduction in gross margin was offset by the
improved absorption of fixed costs over the higher revenue base and reduced
incremental material costs due to volume discounts received in the first two
quarters of 1996.
Selling Expense. Selling expense was $2.5 million for 1996 compared to
$2.1 million for 1995, an increase of $0.4 million or 17%. The increase was
attributable to increased variable costs associated with higher sales activity
in 1996. Selling expense as a percentage of revenues decreased in 1996 compared
to 1995 because of an increase in non-commission sales as a percentage of
revenues. Salaries associated with sales activities were the same for 1996 as
for 1995, as management elected not to expand its sales staff in anticipation
of third and fourth quarter reductions in capital expenditures by semiconductor
manufacturers.
Research and Development Expense. Research and development expense was
$1.9 million for both 1996 and 1995. Compensation expense incurred in research
and development activities for 1996 increased $0.2 million or 22% over 1995 due
to an increase in staffing levels and associated costs. The increase was offset
by a $0.2 million or 45% decrease in amounts spent for materials.
General and Administrative Expense. General and administrative expense was
$1.8 million for 1996 compared to $1.2 million for 1995, an increase of $0.6
million or 55%. The majority of the increase was attributable to additional
compensation and costs associated with newly hired staff in accounting, MIS and
finance functions and salary increases of other administrative personnel.
16
<PAGE>
Income Tax Expense. The Company's effective tax rate decreased slightly in
1996 to 15% compared to 16% for 1995 due principally to a decrease in the
contribution of earnings before income taxes and minority interest from the
Company's foreign subsidiaries.
1995 Compared to 1994
Revenues. Revenues were $14.4 million for 1995 compared to $9.3 million
for 1994, an increase of $5.1 million or 56%. The increase was due to the
higher levels of shipments of the Company's products throughout 1995,
reflecting increased demand as semiconductor manufacturers expanded
manufacturing capacity in excess of historical rates. The increase in revenues
was principally related to volume increases as the Company did not increase
sales prices significantly in 1995. As in 1996, the Company believes the
increase in revenues was attributable to increased sales of products used
during the testing of complex integrated circuits.
Gross Margin. Gross margin was 64% for 1995 compared to 59% for 1994, an
increase of 5%. The improvement in gross margin was primarily the result of
lower incremental material costs due to increased purchasing volume, improved
overhead absorption of fixed costs over the higher revenue base and a 10%
reduction in the percentage of revenues derived from sales to ATE
manufacturers.
Selling Expense. Selling expense was $2.1 million for 1995 compared to
$1.5 million for 1994, an increase of $0.6 million or 42%. The increase was
attributable to increased variable costs associated with the increase in
revenues for 1995 primarily including commissions on sales to semiconductor
manufacturers by independent sales representatives which increased $0.2 million
or 53%. Salaries associated with sales activities also increased $0.2 million
or 56% due to the hiring of additional staff in 1995.
Research and Development Expense. Research and development expense was
$1.9 million for 1995 compared to $1.6 million for 1994, an increase of $0.3
million or 19%. Compensation expense incurred in research and development
activities for 1995 increased $0.1 million or 12% due primarily to salary
increases. In addition, amounts spent for materials increased $0.2 million or
63%.
General and Administrative Expense. General and administrative expense was
$1.2 million for 1995 compared to $1.1 million for 1994, an increase of $0.1
million or 5%, resulting primarily from increased professional expenses related
to patent applications in Europe and Asia and consulting fees.
Income Tax Expense. The Company's effective tax rate declined
significantly in 1995 to 16% compared to 29% for 1994. The decrease was a
function of a significantly greater percentage of earnings before income tax
and minority interest being attributable to the Company's domestic operations
in 1995 (65%) compared to 1994 (26%).
Quarterly Results of Operations
The following tables present certain unaudited consolidated quarterly
financial information for each of the nine quarters ended March 31, 1997. In
the opinion of the Company's management, this quarterly information has been
prepared on the same basis as the Consolidated Financial Statements set forth
elsewhere in this Prospectus and includes all adjustments (consisting only of
normal recurring adjustments) necessary to present fairly the information for
the periods presented when read in conjunction with the Consolidated Financial
Statements and Notes thereto. The results of operations for any quarter are not
necessarily indicative of results for the full year or for any future period.
The Company's business is not seasonal, therefore year-over-year quarterly
comparisons of the Company's results of operations may not be as meaningful as
the sequential quarterly comparisons set forth below which tend to reflect the
cyclical activity of the semiconductor industry as a whole. Quarterly
fluctuations in expenses either are related directly to sales activity and
volume, or tend to be a function of personnel costs and the timing of expenses
incurred throughout a year. See "Risk Factors -- Fluctuations in Revenues and
Operating Results."
17
<PAGE>
<TABLE>
<CAPTION>
Three months ended
-----------------------------------------------
Mar. 31, June 30, Sept. 30, Dec. 31,
1995 1995 1995 1995
---------- ---------- ----------- ----------
(in thousands)
<S> <C> <C> <C> <C>
Consolidated Statement of Earnings Data:
Revenues ................................. $ 3,158 $ 3,094 $ 3,867 $ 4,323
Cost of revenues ........................ 1,441 1,225 1,479 1,046
------- ------- -------- -------
Gross profit ........................... 1,771 1,869 2,388 3,277
------- ------- -------- -------
Operating expenses:
Selling expense ........................ 313 411 576 818
Research and development expense ...... 360 415 491 664
General and administrative expense ...... 205 286 216 459
------- ------- -------- -------
Total operating expenses ............... 878 1,112 1,283 1,941
------- ------- -------- -------
Operating income (loss) .................. 839 757 1,105 1,336
Other income (expense) .................. 15 35 (24) 7
------- ------- -------- -------
Earnings (loss) before income taxes and
minority interest ..................... 854 792 1,081 1,343
Income tax expense ..................... 208 181 109 139
Minority interest ........................ (65) (43) (30) (43)
------- ------- -------- -------
Net earnings (loss) ..................... $ 581 $ 568 $ 942 $ 1,161
======= ======= ======== =======
As a Percentage of Revenues:
Revenues ................................. 100.0% 100.0% 100.0% 100.0%
Cost of revenues ........................ 45.6 39.6 38.2 24.2
------- ------- -------- -------
Gross margin ........................... 54.4 60.4 61.8 75.8
------- ------- -------- -------
Operating expenses:
Selling expense ........................ 9.9 13.3 14.9 18.9
Research and development expense ...... 11.4 13.4 12.7 15.4
General and administrative expense ...... 6.5 9.2 5.6 10.6
------- ------- -------- -------
Total operating expenses ............... 27.8 35.9 33.2 44.9
------- ------- -------- -------
Operating income (loss) .................. 26.6 24.5 28.6 30.9
Other income (expense) .................. 0.5 1.1 (0.6) 0.2
------- ------- -------- -------
Earnings (loss) before income taxes and
minority interest ..................... 27.1 25.6 28.0 31.1
Income tax expense ..................... 6.6 5.8 2.8 3.2
Minority interest ........................ (2.1) (1.4) (0.8) (1.0)
------- ------- -------- -------
Net earnings (loss) ..................... 18.4% 18.4% 24.4% 26.9%
======= ======= ======== =======
<PAGE>
<CAPTION>
Mar. 31, June 30, Sept. 30, Dec. 31, Mar. 31,
1996 1996 1996 1996 1997
---------- ---------- ----------- ---------- -----------
<S> <C> <C> <C> <C> <C>
Consolidated Statement of Earnings Data:
Revenues ................................. $ 6,089 $ 5,043 $ 4,780 $2,670 $ 3,887
Cost of revenues ........................ 1,856 1,732 1,850 1,317 1,602
------- ------- -------- ------ -------
Gross profit ........................... 4,233 3,311 2,930 1,353 2,285
------- ------- -------- ------ -------
Operating expenses:
Selling expense ........................ 781 555 586 549 493
Research and development expense ...... 394 456 425 653 374
General and administrative expense ...... 364 509 453 486 411
------- ------- -------- ------ -------
Total operating expenses ............... 1,539 1,520 1,464 1,688 1,278
------- ------- -------- ------ -------
Operating income (loss) .................. 2,694 1,791 1,466 (335) 1,007
Other income (expense) .................. 12 20 39 30 15
------- ------- -------- ------ -------
Earnings (loss) before income taxes and
minority interest ..................... 2,706 1,811 1,505 (305) 1,022
Income tax expense ..................... 355 290 180 33 167
Minority interest ........................ (94) (86) (67) 34 (11)
------- ------- -------- ------ -------
Net earnings (loss) ..................... $ 2,257 $ 1,435 $ 1,258 ($ 304) $ 844
======= ======= ======== ====== =======
As a Percentage of Revenues:
Revenues ................................. 100.0% 100.0% 100.0% 100.0% 100.0%
Cost of revenues ........................ 30.5 34.3 38.7 49.3 41.2
------- ------- -------- ------ -------
Gross margin ........................... 69.5 65.7 61.3 50.7 58.8
------- ------- -------- ------ -------
Operating expenses:
Selling expense ........................ 12.8 11.0 12.2 20.5 12.7
Research and development expense ...... 6.5 9.0 8.9 24.5 9.6
General and administrative expense ...... 6.0 10.1 9.5 18.2 10.6
------- ------- -------- ------ -------
Total operating expenses ............... 25.3 30.1 30.6 63.2 32.9
------- ------- -------- ------ -------
Operating income (loss) .................. 44.2 35.5 30.7 (12.5) 25.9
Other income (expense) .................. 0.2 0.4 0.8 1.1 0.4
------- ------- -------- ------ -------
Earnings (loss) before income taxes and
minority interest ..................... 44.4 35.9 31.5 (11.4) 26.3
Income tax expense ..................... 5.8 5.7 3.8 1.3 4.3
Minority interest ........................ (1.5) (1.7) (1.4) 1.3 (0.3)
------- ------- -------- ------ -------
Net earnings (loss) ..................... 37.1% 28.5% 26.3% (11.4%) 21.7%
======= ======= ======== ====== =======
</TABLE>
Liquidity and Capital Resources
The Company has funded its working capital requirements principally
through net cash provided by operations. As of March 31, 1997, the Company had
$3.0 million in cash and cash equivalents and $3.9 million in working capital.
Net cash provided by operations was $0.3 million, $5.5 million, $2.7 million
and $1.0 million for the first quarter of 1997, and for the years ended
December 31, 1996, 1995 and 1994, respectively, and principally consisted of
net earnings.
Purchases of machinery, equipment and leasehold improvements in 1996 were
$0.6 million, including $0.2 million to purchase a coordinate measuring machine
for the Company's Cherry Hill, New Jersey facility. In 1996, the Company leased
a 28,630 square foot office and manufacturing facility in Cherry Hill, New
Jersey and spent approximately $0.2 million on leasehold improvements and
furniture costs to outfit this facility, which houses the Company's domestic
manufacturing and customer operations and administrative functions. The Company
also leased 3,077 square feet of office and manufacturing space in Singapore
during 1996 and spent approximately $0.2 million on leasehold improvements and
furniture expenditures to outfit this facility, which houses the Company's
Southeast Asian customer operations office and is anticipated to be utilized
for additional manufacturing operations commencing in 1998.
18
<PAGE>
The Company has a five-year $0.2 million term loan, due in August 2001,
and a $1.5 million revolving line of credit with a commercial bank. The
interest rate on the term loan is fixed at 8.65%, and the revolving line of
credit bears interest at the bank's prime lending rate. The term loan is
collateralized by liens on certain equipment and furnishings located at the
Company's Cherry Hill, New Jersey facility. The revolving line of credit is
collateralized by a pledge of certain assets of inTEST CORP. No amounts were
outstanding under the line of credit as of March 31, 1997 or December 31, 1996.
The Company does not have any capital lease obligations.
The Company believes that existing cash and cash equivalents, its
available line of credit, anticipated net cash provided by operations and the
net proceeds from the offering will be sufficient to meet the Company's cash
requirements for the next 24 months. However, if the Company were to make any
acquisitions, the Company may require additional equity or debt financing to
meet working capital requirements or capital expenditure needs.
Although the Company has historically paid cash dividends to its
stockholders, the Company does not anticipate that it will pay any dividends
for the foreseeable future following the offering, except for the final S
corporation distribution. See "Use of Proceeds," "S Corporation Distributions"
and Note 3 of Notes to Consolidated Financial Statements. The Company intends
to retain future earnings, if any, for reinvestment in the operation and
expansion of the Company's business.
19
<PAGE>
BUSINESS
The Company is a leading independent designer, manufacturer and marketer of
docking hardware and test head manipulators, which are used with automatic test
equipment ("ATE") by semiconductor manufacturers during the testing of wafers
and packaged devices. The Company believes it is a leader based upon its
knowledge and experience in the industry. The Company also designs and markets
related ATE interface products including high performance test sockets,
interface boards and probing assemblies. The Company's products are designed to
improve the utilization and cost-effectiveness of ATE (including testers, wafer
probers and device handlers) during the testing of linear, digital and mixed
signal integrated circuits. Since inception in 1981, the Company has developed
and continues to support over 4,600 products and has been granted 13 U.S.
patents for its technology.
The Company's largest customers include Lucent Technologies, Motorola, SGS
Thomson and Texas Instruments among semiconductor manufacturers, and Credence
Systems, LTX and Teradyne among ATE manufacturers. The Company designs, markets
and supports its products globally both through Company account managers based
in New Jersey, Texas, California, the U.K., Singapore and Japan and through
independent sales representatives in the U.S. and abroad. The Company's
executive offices are located in Cherry Hill, New Jersey. Manufacturing
facilities are located in New Jersey and the U.K.
Industry Background
Testing is an integral and necessary step during the design and
manufacture of wafers and packaged devices. The increasing worldwide demand for
semiconductors in recent years has led to an increase in the demand for ATE.
According to VLSI Research Inc., in 1996 semiconductor manufacturers spent an
estimated $3.7 billion on testers (the test head and mainframe cabinet) and
$1.3 billion on wafer probers and device handlers. The increasing complexity of
wafers and packaged devices, as manifested by larger wafers, higher speeds,
growing pin counts, smaller packaged devices and greater levels of integration
has changed the design, architecture and complexity of ATE used during the
testing of such devices.
Testers range in price from approximately $0.5 million to over $3.0
million each depending primarily on the complexity of the device to be tested
and the number of test heads, typically one or two, with which each tester is
configured. Probers and handlers range in price from approximately $0.1 to $0.5
million. A typical test floor of a large semiconductor manufacturer can have
approximately 100 test heads and 100 probers or 250 handlers available for use
at any one time. Given such a substantial investment, semiconductor
manufacturers employ testing processes which seek to maximize ATE and floor
space utilization.
Each integrated circuit is tested at least twice during the manufacturing
process to ensure the functional and electrical performance of the circuits
prior to shipment to the device user. After wafer fabrication, each circuit on
a wafer is automatically positioned under a probing assembly by a prober where
the individual circuits on the wafer are tested (the "front-end test"). After
device packaging, devices are individually fed by the handler to an
environmentally controlled test socket where the device is again tested (the
"back-end test"). Manipulators facilitate the movement of a test head to a
prober or handler, and "docking" describes the function of connecting a test
head to a prober or handler with mechanically engineered hardware. Shown below
is a schematic depiction of the major steps in the semiconductor manufacturing
process.
[Schematic depiction of the fabrication of an integrated circuit
using blocks to represent each major step of the process from raw
wafer to finished device with special emphasis on "Wafer Test" and
"Final Test."]
Until the early 1970s, testers were designed with the interface circuits
(also referred to as pin electronics) mounted inside the tester's mainframe
cabinet and connected the pin electronics to the prober's probing assembly or
to the handler's test socket via an electrical cable, typically five to ten
feet long. As devices became faster, more complex and more precise, signal
distortion inherent with the use of such cables resulted in degraded test
results. Although certain devices are still tested in this manner, such devices
tend to be used in older, less technologically advanced applications.
20
<PAGE>
During the 1970s, tester manufacturers responded by moving the pin
electronics from the tester's mainframe cabinet to an independent test head,
which could be directly mated with a prober or handler, thereby eliminating the
problems associated with using cables as the connection between the tester's pin
electronics and the prober or handler. Direct mating of the test head pin
electronics to the prober's probing assembly or to the handler's test socket was
accomplished by mounting the test head directly to the prober or handler with a
pivot-mechanism manipulator resembling a waffle iron. Such a combination
resulted in the test head being "dedicated" to only one prober or one handler.
Dedicated manipulators are of greatest value in ATE systems in which the
test head is infrequently disconnected and re-connected to and from one prober
or handler to another prober or handler. Consequently, dedicated manipulators
are used (i) primarily at front-end test, where large, homogeneous lots of
wafers are tested for long, uninterrupted periods of time, and (ii) at back-end
test, where high volume, commodity devices such as DRAMs are tested in large
lots. However, back-end non-commodity devices, such as microcontrollers and
telecommunications devices, generally are tested in smaller lots due to varying
package types and test specifications, thereby requiring frequent handler
changes.
In 1980, free-standing manipulators were introduced to minimize ATE
downtime and increase device testing throughput. Such manipulators used
hand-cranked lead screws to position a test head to a prober or handler. These
early manipulators were only marginally better than the waffle-iron design and
did not significantly improve ATE utilization due to the lack of motion freedom
necessary for successful docking.
Users of these early manipulators attempted to precisely align fragile pin
electronics to test sockets and probing assemblies without docking hardware.
Lack of proper docking hardware often can cause deterioration and damage to the
interface boards, test sockets or probing assemblies. Such damage can lead to
compromised or inaccurate test results and the rejection of good wafers or
devices (yield loss), or, more costly, the acceptance of unsatisfactory wafers
or devices (quality error). In addition, successfully connecting a test head
held by a free-standing manipulator to a prober or handler without docking
hardware is difficult and time-consuming.
The Company's docking hardware and free-standing universal manipulators
are designed to improve the utilization of ATE, particularly ATE employed in
back-end non-commodity flexible testing environments, by facilitating the
quick, easy and safe changeover of test heads to probers and handlers. Shown
below is a graphic representation of a current, typical ATE system
configuration.
[Graphic representation of an ATE test system showing a side-docking
device handler and an in2 test head manipulator holding the test
head in the undocked position. Test head and handler are shown
equipped with in TEST docking hardware.]
21
<PAGE>
The Company's docking hardware products mechanically control the intimate
interface between the test head's interface board and the prober's probing
assembly or handler's test socket. As a result, fragile interface boards, test
sockets or probing assemblies are protected from damage during docking. The
Company's docking hardware allows semiconductor manufacturers to achieve cost
savings by (i) improving ATE utilization, (ii) improving the accuracy and
integrity of test results and (iii) reducing the need to repair or replace
expensive ATE interface products. The Company's docking hardware can be
designed for use with substantially all makes and models of test heads, probers
and handlers, and can usually be designed to allow all the ATE on a test floor
to be mechanically plug-compatible. Plug-compatibility simplifies the docking
procedures, allowing for increased flexibility and utilization of test heads,
probers and handlers on a test floor.
The Company's free-standing universal manipulators are designed to be used
in either a dedicated or a flexible test environment. In addition, the
Company's manipulators have been engineered to hold test heads in what seeks to
replicate a "zero gravity" free space. As a result, an operator using no more
than 22 pounds of force can reposition the test head by grasping it in his or
her hands and gently moving the test head into position to dock with a prober
or handler. Test heads currently in use weigh up to approximately 900 pounds
and measure up to a cubic yard in volume.
A test head held in the Company's free-standing universal manipulator and
equipped with the Company's docking hardware can be easily, quickly and safely
docked to any handler. After testing a particular production lot of devices,
the test head can quickly and easily be disconnected and docked to another
handler for testing either a subsequent lot of the same packaged device or to
test a different device.
The continued development of more complex devices will require faster,
higher pin count, and larger and heavier test heads. The Company believes that
semiconductor manufacturers will continue to demand docking hardware and
manipulators which exhibit corresponding design changes and improvements in
utilization and functionality.
Strategy
The Company's goals are to supply the highest quality docking hardware,
test head manipulators and related ATE interface products, and to provide the
most cost effective ATE interface solutions to the semiconductor industry. The
following elements, all of which are interrelated, form the basis of inTEST's
strategy:
Capitalize on Experience and Expertise. Over the past 15 years, the
Company has developed numerous generations of docking hardware and test head
manipulators. The Company has designed, and continues to support, over 4,600
unique products and maintains over 5,100 computerized engineering drawings.
Substantially all of the Company's products are customized to a customer's
particular ATE system configuration. As a result, the Company has accumulated
substantial technical design expertise, evidenced in part by having been
granted 13 U.S. patents to date, with two U.S. patent applications pending. The
Company's product development efforts are focused on the needs of semiconductor
manufacturers and seek to establish the Company's docking hardware and
manipulator products as the industry standard. For example, the Company is
currently developing a new series of fully-automatic, microprocessor-controlled
dedicated manipulators (the Test Head Hoist). These manipulators are primarily
designed for front-end wafer and back-end commodity device testing, two market
segments which the Company has not traditionally targeted.
Maintain Customer Relationships. As an independent provider of docking
hardware and test head manipulators, the Company has cultivated and maintains
close working relationships with nearly all major semiconductor and ATE
manufacturers. The long term and interactive nature of such customer
relationships provides the Company's account managers with hands-on knowledge
of leading-edge test procedures, test room protocol, ATE systems and the
economics of testing. The Company works with its customers in identifying ATE
interface problems, defines and custom designs product solutions, installs the
Company's products and provides post- installation follow-up and operational
support. The Company believes that by maintaining such relationships, it will
be able to respond quickly to new ATE interface applications. The Company
believes that its direct access to a broad and diversified base of ATE system
environments provides it with an important competitive advantage.
Expand International Presence. The Company intends to add manufacturing
capabilities to its existing facility in Singapore in 1998 and to consider
establishing operations in other key back-end markets such as
22
<PAGE>
China, Malaysia, the Philippines, Taiwan or Thailand. The Company believes that
proximity to semiconductor manufacturers enables the Company to respond more
quickly and accurately to its customers' needs. In addition, employing account
managers native to such markets minimizes language and cultural barriers and
provides market-specific technical and operational insight.
Pursue Complementary Acquisitions. The Company will seek to acquire
businesses (domestic or foreign), technologies or products that are
complementary to the Company's docking hardware and manipulator products,
including related ATE interface products that must be replaced periodically and
could result in additional recurring revenues. The Company is not currently a
party to any agreement or understanding with respect to any acquisition, nor
has it identified any specific acquisition targets. However, there are numerous
companies which manufacture related ATE interface products that the Company
believes could enhance its ability to provide its customers with the means to
improve the efficiency and cost-effectiveness of semiconductor testing
processes. The Company does not intend to expand its lines of docking hardware
and manipulators by acquisition, nor to acquire tester, prober or handler
manufacturers.
Products
The Company designs, manufactures and markets docking hardware and test
head manipulators used by semiconductor manufacturers during the testing of
wafers and packaged devices. The Company also designs and markets related ATE
interface products. The Company's products are designed to improve the
utilization and cost-effectiveness of testers, wafer probers and device
handlers. Substantially all of the Company's products are customized for use
with particular ATE and, in the case of docking hardware, also to achieve
plug-compatibility among particular combinations of ATE. The Company's docking
hardware, manipulators and related ATE interface products are designed for use
with more than 175 test heads, 30 probers and 300 handlers, all of which are
mechanically unique makes and models. The Company has designed and continues to
support more than 4,600 products, any of which can be manufactured upon
request.
23
<PAGE>
Docking Hardware and ATE Interface Products
The Company's docking hardware is designed for use with floating-head
universal manipulators, which are used when maximum mobility and
inter-changeability of handlers between test heads is required. The Company's
docking hardware provides the mechanical control to safely connect, with near
zero electrical length, the test interface board with either the probing
assembly on a prober or the test socket on a handler. A simple cam action docks
and locks the test head to the prober or handler so that the two become a
single mechanism which prohibits motion of the test head relative to the prober
or handler. This minimizes deterioration of the interface boards, test sockets
and probing assemblies caused by the constant vibration characteristic of the
operation of all probers and handlers. The Company's docking hardware allows an
operator to manually align the probing assembly or test socket to within .005"
with respect to the interface board on the test head. Shown below is a graphic
representation of a test head and handler in the un-docked position.
[Graphic representation of a test head and handler in the un-docked
position showing details of inTEST docking hardware.]
The Company offers six standard four-cam families and three standard
three-cam families with load ratings of 200, 400 and 600 pounds. The Company's
docking families are primarily distinguished from one another by the number of
docking cams and guide pins, the load rating and the size of test head
interface boards that can be used with each particular family of docking
hardware. The Company's docking hardware products range in price from
approximately $2,000 to $12,000.
The Company's docking hardware products are distinguished from those
offered by ATE manufacturer competitors by the ability of the Company's
products to make multiple competing brands of test heads plug-
compatible with multiple brands of probers and handlers used by a semiconductor
manufacturer by only changing interface boards. Creating such
plug-compatibility requires detailed information about competing ATE that would
generally not be available to a competing ATE manufacturer. Plug-compatibility
permits non-commodity semiconductor manufacturers to reduce the changeover time
required to un-dock a test head from one handler and dock it to another handler
between production lots or when changing the device type being tested.
24
<PAGE>
In addition, the Company designs and sells a variety of related ATE
interface products including high performance test sockets, interface boards,
probing assemblies and other products. The Company custom designs all docking
hardware and related ATE interface products for the specific combinations of
test heads and probers or handlers used by its customers.
Manipulator Products
in2 Test Head Positioner. The in2 Test Head Positioner ("in2") is a
universal manipulator which can be designed to hold any test head. A universal
manipulator enables the test head to be repositioned for alternate use with any
one of several probers or handlers on a test floor. The in2 is distinguished
from universal manipulators manufactured by competitors by its innovative,
floating-head design. The design of the in2 allows a test head to be held in an
effectively weightless state, moved up or down, right or left, forward or
backward and rotated around each axis (six degrees of motion freedom) by an
operator using no more than 22 pounds of force. Consequently, an operator can
manually reposition the test head by grasping it in his or her hands and gently
moving the test head into position to dock with the prober or handler. This
same design feature allows the operator to dock the test interface board (which
is used to connect the test head's pin electronics to the probing assembly on a
prober or to the test socket on a handler) with near zero electrical length
between the pin electronics and the probing assembly or the test socket, while
protecting the fragile electrical contacts from inadvertent damage during the
docking action.
The Company manufactures six styles of the in2, all of which are available
in eight different load-rated sizes. The styles include one tumble mode style
and five cable pivot style manipulators. Each style provides a distinct
combination of performance characteristics suited to different customer
applications. A tumble mode positioner might be specified for various reasons
including test head form factor, compatibility with in-line automation, cable
support simplicity or cost minimization. Reasons for specifying a cable pivot
positioner could include providing improved handling characteristics necessary
for larger test heads, the ability to handle test heads with short
mainframe-to-test head cables or the necessity to position the test head close
to the floor. In addition, the Company designs telescopic cable supports to be
used with its cable pivot manipulators; these cable supports minimize bending
and twisting stress to mainframe-to-test head cables, which can be delicate yet
weigh several hundred pounds. The in2 ranges in price from approximately
$12,000 to $100,000 depending upon load capacity, manipulator style and the
type of cable management.
Test Head Hoist. In July 1996, the Company introduced a new,
fully-automatic, electrically-powered and microprocessor-controlled dedicated
manipulator called the Test Head Hoist ("THH"). The patented, overhead design
of the THH series manipulator uses a powered scissor mechanism to raise and
lower a test head to a prober or a top docking handler. This design enables a
THH to dock very large test heads (weight tested to 1,000 pounds) within .005".
Shown below is a graphic representation of the THH.
[Graphic representation of the Test Head Hoist with test head and
prober shown from 3/4 front view.]
25
<PAGE>
Although the Company has had no sales of the THH series manipulator to
date, the Company believes that the THH series of manipulators will be
attractive to semiconductor manufacturers for testing 300 mm wafers and
packaged memory devices. The Company's THH is the only fully-automatic
manipulator which enables a test head to be automatically docked to a prober or
handler with the push of one button. The Company believes that the THH enables
semiconductor manufacturers to increase floor space utilization of their ATE
test systems by 25% to 40% over that achieved by waffle-iron style dedicated
manipulators or universal manipulators because a THH series manipulator has a
virtually zero "footprint." The Company does not expect significant sales of
the THH manipulators before 1999.
Markets and Customers
The Company markets its products globally to semiconductor manufacturers
and, to a lesser extent, ATE manufacturers on an OEM basis. The Company believes
that it sells to most major semiconductor manufacturers in the world. The
Company's docking hardware and universal manipulators are primarily used during
back-end testing of non-commodity packaged devices. Such devices include
linear, digital and mixed signal integrated circuits (such as microprocessors,
digital signal processing chips, ASICs and non-commodity memory devices) and
primarily have applications in the automotive, computer, consumer products and
telecommunications industries.
The Company believes its sales of docking hardware and manipulators are a
function of the general level of capital expenditures by semiconductor
manufacturers. In addition, the Company's sales of docking hardware generally
are driven by changes in device designs or test methods, industry-wide volume
of device testing, sales of new handlers and, to a lesser extent, sales of new
test heads. In the past, sales of the Company's docking hardware generally have
been strong when spending for test heads was low. During such times, the
Company believes that semiconductor manufacturers seek to improve the
utilization, performance and efficiency of existing ATE by purchasing docking
hardware. The Company's sales of manipulators generally follow purchases of
test heads by the Company's semiconductor manufacturer customers. The Company
believes its sales of related ATE interface products primarily depend upon
operating expenditures of the Company's semiconductor manufacturer customers.
Both North American and European semiconductor manufacturers have located
most of their back-end factories in Southeast Asia. The front-end wafer
fabrication plants of U.S. semiconductor manufacturers are primarily in the
U.S. Likewise, European, Taiwanese, South Korean and Japanese semiconductor
manufacturers primarily have located their wafer fabs in their respective
countries. The Company's sales to Japanese semiconductor manufacturers
primarily consist of test sockets and interface boards. Sales of docking
hardware and universal manipulators have been limited in Japan and South Korea
because manufacturers in these countries emphasize mass-produced products such
as memory devices and other commodity devices. Commodity devices are typically
tested using dedicated manipulators rather than universal manipulators with
docking hardware.
As part of the Company's strategy to be domiciled in its major markets,
the Company established inTEST LTD in the U.K. in 1985, inTEST KK in Japan in
1987 and inTEST PTE in Singapore in 1990. inTEST LTD designs, manufactures and
markets the Company's products principally in the European market. inTEST KK
was established to be a liaison office with Japanese ATE manufacturers and to
market inTEST products in Japan. In addition, inTEST KK initiated the Company's
business of designing and marketing related ATE interface products. inTEST PTE
designs, markets and provides technical support to customers in Southeast Asia,
and it intends to commence manufacturing operations in Singapore in 1998.
The Company has maintained long term relationships with substantially all
ATE manufacturers. The Company believes its relations with such manufacturers
are good and have been additionally strengthened due to the fact that the
Company does not compete with such manufacturers for testers, probers and
handlers. The Company believes that maintaining such relationships is essential
to its ability to provide plug-compatible ATE interface solutions.
26
<PAGE>
The following semiconductor and ATE manufacturers have each purchased at
least $250,000 of the Company's products since the beginning of 1994:
Analog Devices National Semiconductor
Credence Systems NEC
Harris Philips Electronics
Hewlett Packard Schlumberger
Intel SGS Thomson
LTX Symbios Logic
Lucent Technologies Teradyne
Matsushita Texas Instruments
Microchip Technologies Tokyo Electron
Motorola Xilinx
The Company's largest customers include Lucent Technologies, Motorola, SGS
Thomson and Texas Instruments among semiconductor manufacturers, and Credence
Systems, LTX and Teradyne among ATE manufacturers. See "Risk Factors --
Customer Concentration."
Manufacturing and Supply
The Company's principal manufacturing operations consist of assembly and
testing at its facilities in New Jersey and in the U.K. In 1998, the Company
plans to commence similar operations in its Singapore facility. The Company
believes that it is able to respond more quickly and accurately to its
customers needs by maintaining manufacturing facilities and technical support
in geographic markets where its semiconductor manufacturer customers are
located.
The Company assembles its docking hardware, manipulator products and
certain of its probing assemblies from a combination of standard components and
fabricated custom parts which have been manufactured to the Company's
specifications by third manufacturers. The Company's related ATE interface
products, such as test sockets, interface boards and other of its probing
assemblies, are also manufactured to the Company's specifications by third
party manufacturers. The Company's policy is to use the highest quality raw
materials and components in its products. The primary raw materials used in
fabricated parts are various grades of aluminum and steel, in interface boards
are fiberglass and copper and in test sockets are plastic and copper, all of
which are widely available. Substantially all components are purchased from
multiple Suppliers. Certain raw materials and components are purchased from
single Suppliers. However, the Company believes that all materials and
components are available in adequate amounts from other sources. See "Risk
Factors -- Dependence on Key Suppliers."
In New Jersey, the Company controls the quality of raw materials,
fabricated parts and components by conducting incoming inspections using
sophisticated measurement equipment, including a coordinate measuring machine,
to ensure that products with critical dimensions meet the Company's
specifications. In the U.K., the Company relies upon its Suppliers for
inspecting the quality of fabricated parts. The Company intends to buy a
coordinate measuring machine for inTEST LTD by the end of 1997. The Company's
policy is to inspect all products at various stages prior to shipment. The
Company's inspection standards have been designed to comply with applicable MIL
specifications and ANSI standards. The Company is preparing a quality manual to
comply with such specifications and standards in anticipation of applying for
ISO 9001 certification.
Sales and Distribution
In North America, the Company sells to semiconductor manufacturers
principally through independent, commissioned sales representatives and to ATE
manufacturers through Company account managers. North American sales
representatives also coordinate product installation and support with the
Company's technical staff and participate in trade shows. Technical support is
provided to the Company's North American customers and independent sales
representatives by Company employees based in Cherry Hill, New Jersey,
Sunnyvale, California and Austin, Texas.
27
<PAGE>
In Europe, the Company sells to semiconductor and ATE manufacturers
through Company account managers, except in Belgium and Holland where the
Company uses an independent sales representative. In Japan, the Company sells
to semiconductor and ATE manufacturers through Company account managers. In
China, Hong Kong, Malaysia, the Philippines, Singapore, South Korea, Taiwan and
Thailand, the Company sells through independent sales representatives.
International sales representatives are responsible for sales, installation,
support and trade show participation in their geographic market areas.
Company account managers are responsible for a portfolio of customer
accounts and for managing certain independent sales representatives. In
addition, Company account managers are responsible for applications
engineering, custom product design, pricing, quotations, proposals and
transaction negotiations.
Competition
The Company's competitors include independent manufacturers of docking
hardware, manipulators and related ATE interface products, designers and
manufacturers of ATE and, to a lesser extent, semiconductor manufacturers'
in-house ATE interface groups. The Company principally competes on the basis of
product performance and functionality, product reliability, customer service,
applications support, price and timely product delivery.
The independent manufacturers of docking hardware and manipulators which
compete with the Company include Reid-Ashman Manufacturing of the U.S.,
Microhandling of Germany and Shang Sheng of Taiwan, each of which manufactures
docking hardware and manipulators. The manufacturers of ATE which compete with
the Company in the sale of docking hardware and universal manipulators include
Credence Systems, LTX, Schlumberger and Teradyne. Such manufacturers of ATE may
be both competitors and customers of the Company. In addition, in the sale of
related ATE interface products there are approximately 20 manufacturers of
interface boards, four manufacturers of high performance test sockets and eight
manufacturers of probing assemblies. See "Risk Factors -- Competition."
Patents and Other Proprietary Rights
The Company currently holds 13 U.S. patents and 64 foreign patents and has
pending two U.S. patent applications and more than 30 foreign applications that
cover various aspects of its technology. The Company's policy is to protect its
technology by filing patent applications for the technologies that the Company
considers important to its business. The Company first filed for patent
protection in the U.S. for its docking hardware and the in2 test head
manipulator in 1982, less than one year after the formation of the Company.
The Company also relies on trade secrets and unpatentable knowhow to
protect its proprietary rights. It is the Company's policy to require, as a
condition of permanent employment, that all employees of the Company agree to
assign to the Company all rights to inventions or other discoveries relating to
the Company business made while employed by the Company. In addition, all
employees agree not to disclose any information regarding the Company which is
private or confidential.
The Company has notified one of its competitors that the Company believes
the competitor's products infringe on one of the Company's U.S. patents. The
competitor responded by alleging that certain claims of the patent are invalid
based on an earlier issued U.S. patent. The Company, in order to strengthen its
patent position, requested reexamination of its patent by the U.S. Patent and
Trademark Office (the "PTO") over that earlier issued U.S. patent. The
competitor thereafter also requested a reexamination of the patent. A
reexamination provides the PTO with an opportunity to reevaluate the validity
of the claims of a patent previously issued by the PTO. On April 7, 1997, the
PTO issued an Office Action in Reexamination confirming five of the nine claims
of the Company's patent, and rejecting four claims. On April 29, 1997, the
Company's patent attorney presented to the Examiner in charge of the
Reexamination a minor amendment to the claims. In response, the Examiner agreed
that the proposed amendment appears to overcome the rejection of the four
claims. Based on advice of its patent counsel, the Company believes that upon
formal submission of the proposed amendment, all claims will be deemed
patentable and the Commissioner of the PTO will issue a Certificate of
Reexamination to that effect. Although there can be no assurance, the Company
believes that the failure of the PTO ultimately to deem patentable some or all
of the four claims rejected in the Office Action will not have a material
adverse effect on the Company's business or results of operations. See
"Business--Patents and Other Proprietary Rights."
28
<PAGE>
Computer Systems
The Company maintains an MIS system at each of its facilities. These
systems are designed to (i) process all quotations, sales orders, work orders,
and purchase orders; (ii) plan, control and allocate inventory; (iii) plan and
schedule production; (iv) cost and price products; and (v) maintain accounting
and financial records. The MIS systems provide a central database of price
lists, product descriptions, applications data, design manuals and engineering
documentation and are simultaneously accessible by all employees of the
Company. In addition, the MIS systems prompt the actions of many of the
employees of the Company, including designers, buyers and inspectors. The MIS
systems, which are fully integrated, interactive and real-time, have been
extensively customized by both Company employees and outside consultants. The
MIS systems control the Company's inventory of approximately 12,000 fabricated
parts, 6,000 purchased parts, 11,000 finished goods and 1,000 sub-
assemblies.
The Company utilizes LAN-based CAD systems at each of its facilities. The
CAD systems currently contain over 4,000 of the Company's 7,600 fabrication
drawings and over 1,100 of the Company's 1,800 customer drawings of product
applications, floor plans and operating procedures. All new designs and
drawings are created in CAD and engineering changes are published as CAD
drawings as the changes are adopted.
Backlog
At March 31, 1997, the Company's backlog of unfilled orders for all
products was approximately $2.3 million compared with approximately $4.3
million at March 31, 1996. The Company's backlog includes customer purchase
orders which have been accepted by the Company. Although backlog generally is
shipped within 45 days, the backlog at March 31, 1996 was unusually high and
was shipped over the next 70 days. The Company's backlog at March 31, 1997
represents shipments which are expected to be made in 40 to 45 days. While
backlog is calculated on the basis of firm purchase orders, no assurance can be
given that customers will purchase the Company's products subject to such
orders. As a result, the Company's backlog at a particular date is not
necessarily indicative of sales for any future period. See "Risk Factors --
Dependence upon Semiconductor Industry" and "Management's Discussion and
Analysis of Financial Condition and Results of Operations."
Employees
At March 31, 1997, the Company had 61 employees, including 26 in customer
operations, 21 in manufacturing operations and 14 in administration.
Substantially all of the Company's key employees are highly skilled and trained
technical personnel, and new technical employees are required to attend an
in-house training program. None of the Company's employees are represented by a
labor union, and the Company has never experienced a work stoppage. The Company
believes that its employee relations are excellent.
Facilities
The Company's headquarters are located in Cherry Hill, New Jersey in
28,630 square feet of office and manufacturing space leased pursuant to a
seven-year lease which expires in 2003. The Company's facility in the U.K. is
located in Thame in 4,600 square feet of office and manufacturing space leased
pursuant to an assumed, 20-year lease which expires in December 1997. The
Company is currently negotiating renewal terms for this lease. In Singapore,
the Company occupies 3,077 square feet of office and manufacturing space leased
pursuant to a four-year lease which expires in 2000 subject to a two-year
renewal option. In Kichijoji, Japan, the Company occupies approximately 1,200
square feet of office space pursuant to an agreement which is cancelable on
reasonable notice by either party. In Sunnyvale, California, the Company
occupies 1,900 square feet of office and warehouse space leased pursuant to a
five-year lease which expires in 2001. The Company believes that its
headquarters and other existing facilities are adequate to meet its current and
foreseeable future needs.
29
<PAGE>
MANAGEMENT
Executive Officers, Directors and Significant Employees
The executive officers and directors of the Company are as follows:
<TABLE>
<CAPTION>
Name Age Position
- ---- --- --------
<S> <C> <C>
Alyn R. Holt (1) ..................... 59 Chairman and Chief Executive Officer
Robert E. Matthiessen (1)(2) ......... 52 President, Chief Operating Officer and Director
Daniel J. Graham (1) .................. 51 Senior Vice President and Director
Hugh T. Regan, Jr. .................. 37 Chief Financial Officer and Treasurer
Hugh T. Regan, Sr. .................. 62 Secretary
Richard O. Endres (2)(3) ............ 71 Director
Stuart F. Daniels, Ph.D. (2)(3) ...... 56 Director
</TABLE>
- ------------
(1) Member of the Executive Committee
(2) Member of the Compensation Committee
(3) Member of the Audit Committee
Other significant employees of the Company include:
Name Age Position
- ---- --- --------
Jack R. Edmunds ...... 56 Director of Operations, inTEST CORP
Brian R. Moore ...... 60 Managing Director, inTEST LTD
Tomoyasu Ogura ...... 47 Representative Director, inTEST KK
Cornelis Hol ......... 59 Managing Director, inTEST PTE
Directors are elected by the stockholders at the Company's annual meeting
of stockholders. Each director is elected to serve for a term of one year or
until his successor is elected and qualified. Executive officers are appointed
by the Board of Directors of the Company. Each executive officer is appointed
to serve until the first meeting of the Board of Directors after the annual
meeting of stockholders next succeeding his election and until his successor is
elected and qualified.
Alyn R. Holt is a co-founder of the Company and has served as Chairman and
Chief Executive Officer since the Company's inception in September 1981. Mr.
Holt has over 35 years experience in the ATE industry, including various
positions in general management, marketing management and engineering. From
1973 to 1980, Mr. Holt was Manager of the Measurement Systems Division of
Siemens Corporation. From 1966 to 1973, he served in various capacities
including Vice President of Marketing for Computest Corporation, a manufacturer
of ATE for the computer industry. Mr. Holt is a co-inventor on several of the
Company's patents. Mr. Holt holds an M.B.A. from California State University
and a B.S. in Electrical Engineering from South Dakota State University.
Robert E. Matthiessen was elected President, Chief Operating Officer and a
Director of the Company in February 1997. Prior to that, Mr. Matthiessen served
as Executive Vice President since joining the Company in October 1984. He has
over 25 years experience in the ATE industry, including various positions in
general management, marketing management and engineering management. In 1982,
Mr. Matthiessen co-founded a company engaged in the production of video
products for training, advertising and sales, and served as its President from
inception to 1984. From 1973 to 1981, he served in various engineering and
marketing management positions with the Measurement Systems Division of Siemens
Corporation. Mr. Matthiessen is a co-inventor on several of the Company's
patents. He studied electrical engineering at Drexel University and business
administration at Rutgers University.
Daniel J. Graham is a co-founder of the Company and has served as Senior
Vice President and a Director of the Company since 1988. Prior to that, Mr.
Graham served as Vice President of the Company since the Company's inception.
Mr. Graham has expertise in integrated circuit test technology and operated his
own software consulting firm from 1978 to 1992. He has over 25 years industrial
experience involving the development of
30
<PAGE>
software and hardware systems for ATE. Mr. Graham is a past Chairman of the
Test Technology Technical Committee of the Institute of Electrical and
Electronic Engineers, Inc. (the "IEEE") Computer Society. He currently serves
as General Vice Chair of the International Test Conference which is sponsored
by the IEEE. He holds an M.S. in Computer and Information Science Engineering
from the University of Pennsylvania and a B.S. with honors in Electrical
Engineering from the Queen's University of Belfast, Northern Ireland.
Hugh T. Regan, Jr. has served as the Company's Chief Financial Officer and
Treasurer since joining the Company in April 1996. From 1989 to 1995, Mr. Regan
was the Vice President of Finance for Value Property Trust, a publicly traded
real estate investment trust (the "Trust"). From 1995 until he joined the
Company, Mr. Regan was the Chief Financial Officer of the Trust. Mr. Regan
holds a B.S. in Accounting and Finance from Rider University and is a Certified
Public Accountant.
Hugh T. Regan, Sr. has served as the Company's Secretary since 1982. Mr.
Regan was Chief Financial Officer of the Company from 1982 to 1996. He has
served as President of his accounting firm, Regan Accounting Services, since
1986. He has over 35 years of financial and general management experience in
the computer, ATE and other industries. From 1979 to 1983, he was Executive
Vice President and Chief Financial Officer of Emery Corporation, a home
furnishings manufacturing company. From 1973 to 1979, he was Vice President of
Finance and Chief Financial Officer of Clarke Corporation, a publicly traded
building products manufacturing company. From 1966 to 1973, he was Controller
for Computest Corporation, an early leader in ATE. Mr. Regan holds a B.S. in
Business Administration and Accounting from LaSalle University.
Richard O. Endres has served as a Director of the Company since April
1982. He has served as President of VRA, Inc., which provides business planning
and financial services for start-up companies, since 1976. Mr. Endres founded
Computest Corporation in 1962 and served as its President from 1962 to 1973.
Computest was sold to Siemens Corporation in 1973, at which time Mr. Endres
became Group Vice President for Siemens until 1976. From 1948 to 1953, Mr.
Endres was engaged in early transistor circuit development and computer memory
research at RCA's David Sarnoff Research Center. Mr. Endres holds a B.S. in
Electrical Engineering from Purdue University.
Stuart F. Daniels, Ph.D. is a co-founder of the Company and served as Vice
President and a Director in 1982 and was reappointed as a Director in April
1997. In 1996, Dr. Daniels founded The Daniels Group, which is engaged in
technology transfer and license consulting. From 1980 to 1995, Dr. Daniels held
several management positions with Siemens Corporation. Dr. Daniels also
co-founded Digital General Corp., an ATE company, in 1969. Dr. Daniels holds a
Ph.D. in Electrical Engineering from Case Western Reserve University, an M.S.
in Electrical Engineering from Case Institute of Technology and a B.S. in
Electrical Engineering from the University of New Hampshire. He is also an
adjunct of the Computer Information Science Department at the New Jersey
Institute of Technology. Dr. Daniels holds two patents in ATE technology.
Jack R. Edmunds has served as Director of Operations since joining the
Company in September 1987. He has over 20 years experience in the ATE industry,
including various positions in operations management, marketing management,
engineering and sales. From 1964 to 1975 he held numerous management positions
in operations, engineering, marketing and sales with Computest Corporation. He
studied business administration at Rutgers University.
Brian R. Moore has served as the Managing Director of inTEST LTD since
February 1985. From 1982 to 1985, Mr. Moore was a managing partner in Anglo
European Machinery Company, a manufacturer of test head manipulators and other
specialty machines for the ATE industry, which was acquired by inTEST LTD in
1985. He has over 35 years experience in the ATE industry, including various
positions in general management, engineering management, operations management,
marketing and mechanical design. Mr. Moore is a co-inventor on several of the
Company's patents. He studied mechanical engineering at High Wycombe Technical
College in the U.K.
Tomoyasu Ogura has served as the Representative Director of inTEST KK
since March 1990. Prior to that, Mr. Ogura was Marketing Manager of inTEST KK
since May 1988. From 1981 to 1988, Mr. Ogura was the Technical Manager for a
subsidiary of C. Itoh & Co., a trading company. He has over 20 years experience
in the ATE industry in Japan, including various positions in general
management, sales management, marketing, engineering and sales. Mr. Ogura holds
a B.S. degree in Electrical Engineering from Kanagawa University, Yokohama.
31
<PAGE>
Cornelis Hol has served as the Managing Director of inTEST PTE since its
inception in April 1990 and as Director of inTEST KK since its inception in
1987. Mr. Hol is also Managing Director of C. Hol Business Development, a
management consulting company he founded in 1986 with which the Company has a
contract for the management of inTEST PTE. In addition, from 1993 to 1995, Mr.
Hol was President of Intertrade Scientific, Inc. ("ITS"), a distributor of
semiconductor production equipment in the U.S., and Managing Director of ITS in
Munich, Germany. He has over 15 years experience in the semiconductor industry
in Southeast Asia, Japan, Europe and the U.S., including various positions in
general management, sales and distribution management. From 1981 to 1986, Mr.
Hol was Managing Director of MCT Asia, a manufacturer of device handlers. Mr.
Hol holds a Marine Engineering degree from De Ruyter School, Flushing, Holland.
Hugh T. Regan, Jr. is Hugh T. Regan's son; there are no other family
relationships between any of the directors or executive officers of the
Company. Dr. Daniels has agreed to provide consulting services to the Company
including analyzing patents and other intellectual properties relating to the
Company's technology interests, for which he will be compensated for his
services at a rate of $150 per hour. The Company does not expect the consulting
fees paid to Dr. Daniels to exceed $25,000 per year. Non-employee directors are
paid a quarterly retainer of $2,500, a fee of $2,000 per board meeting and a
fee of $1,000 per committee meeting that falls on a day other than a board
meeting. In addition, non-employee directors are reimbursed travel expenses and
other costs associated with attending board or committee meetings. The Company
does not pay additional cash compensation to officers of the Company for their
service as directors of inTEST CORP. However, officers who serve as directors
of the Company's foreign subsidiaries receive compensation as approved each
year by such subsidiary's Board of Directors. The Company intends to hold at
least four meetings of the Board of Directors per year. Directors are also
eligible to participate in the Company's 1997 Stock Plan. See " -- 1997 Stock
Plan" and " -- Executive Compensation."
Board Committees
The Board of Directors has three standing Committees: an Executive
Committee, an Audit Committee and a Compensation Committee. The Executive
Committee is responsible for those duties delegated to it by the Board of
Directors. The Audit Committee reviews the results and scope of the audit and
other services provided by the Company's independent auditors. The Compensation
Committee makes recommendations concerning salaries and incentive compensation
for employees of the Company and administers the Company's stock option and
bonus plan. See " -- 1997 Stock Plan."
32
<PAGE>
Executive Compensation
The following table sets forth certain information with respect to the
compensation paid by the Company for services rendered during the years ended
December 31, 1996, 1995 and 1994, to its Chairman and Chief Executive Officer
and the other executive officers of the Company whose total annual salary and
bonus exceeded $100,000 during such period (each, a "Named Executive Officer").
Summary Compensation Table
<TABLE>
<CAPTION>
Annual Compensation
---------------------------------------
Other annual All other
Name and Principal Position Year Salary Bonus compensation compensation
- ------------------------------ ------ ---------- --------- -------------- ----------------
<S> <C> <C> <C> <C> <C>
Alyn R. Holt ............... 1996 $155,545 $55,234 $ 47,693(1) $ 145,851(2)
Chairman and Chief 1995 121,300 44,631 19,876(1) 86,557(2)
Executive Officer 1994 112,530 18,280 25,337(1) 20,250(2)
Robert E. Matthiessen ...... 1996 $ 97,020 $ 6,750 $ 13,578(3) $ 5,720(4)
President, Chief Operating 1995 92,620 -- 14,095(3) 756(4)
Officer and Director 1994 89,217 -- 21,567(3) 756(4)
Daniel J. Graham ............ 1996 $105,200 -- $ 18,943(5) $ 35,539(6)
Senior Vice President and 1995 100,000 -- 19,376(5) 45,795(6)
Director 1994 95,503 -- 20,097(5) 17,116(6)
Hugh T. Regan, Sr. (7) ...... 1996 $113,635 -- -- $ 27,628(8)
Secretary 1995 106,150 -- -- 23,295(8)
1994 95,550 -- -- 15,650(8)
</TABLE>
- ------------
(1) Includes: $39,500 for the annual lease value of automobiles for Alyn R. and
Connie E. Holt in 1996, and $11,250 and $10,250 for Mr. Holt in 1995 and
1994, respectively; $6,793, $7,426 and $14,087 for group health insurance
in 1996, 1995 and 1994, respectively.
(2) Includes: $3,046, $2,724 and $2,724 for premiums paid on life insurance for
Mr. Holt in 1996, 1995 and 1994, respectively; $4,486 matching
contribution to Mr. Holt's 401(k) Plan account in 1996; and $138,319,
$83,833 and $17,526 for serving as a director of inTEST LTD and inTEST KK
in 1996, 1995 and 1994, respectively.
(3) Includes: $8,750, $7,750 and $10,250 for the annual lease value of an
automobile for Mr. Matthiessen in 1996, 1995 and 1994, respectively;
$4,828, $5,345 and $11,317 for group health insurance in 1996, 1995 and
1994, respectively.
(4) Includes: $1,184, $756 and $756 for premiums paid on life insurance for Mr.
Matthiessen in 1996, 1995 and 1994, respectively; and $4,536 matching
contribution to Mr. Matthiessen's 401(k) Plan account in 1996.
(5) Includes: $10,750, $10,750 and $7,550 for the annual lease value of an
automobile for Mr. Graham in 1996, 1995 and 1994, respectively; $6,793,
$7,426 and $11,317 for group health insurance in 1996, 1995 and 1994,
respectively.
(6) Includes: $2,107, $1,436 and $1,466 for premiums paid on life insurance for
Mr. Graham in 1996, 1995 and 1994, respectively; $4,750 matching
contribution to Mr. Graham's 401(k) Plan account in 1996; and $28,682,
$44,359 and $15,650 for serving as a director of inTEST LTD and inTEST KK
in 1996, 1995 and 1994, respectively.
(7) Mr. Regan served as the Company's Chief Financial Officer through April
1996.
(8) Includes: $785 for premiums paid on life insurance for Mr. Regan in 1996;
$1,920 matching contribution to Mr. Regan's 401(k) Plan account in 1996;
and $24,923, $23,295 and $15,650 for serving as a director of inTEST LTD
in 1996, 1995 and 1994, respectively.
33
<PAGE>
401(k) Plan
The inTEST Corporation 401(k) Savings Incentive Plan (the "401(k) Plan")
became effective on January 1, 1996. All employees of inTEST CORP who are at
least 18 years of age and have completed six months of service with the Company
are eligible to participate in the 401(k) Plan. An eligible employee may elect
to contribute up to 15% of his or her compensation each year instead of
receiving that amount in cash, up to the legal limit (the limit for 1997 is
$9,500). The Company will match employee contributions up to 10% of an
employee's compensation, not to exceed $4,750. At the discretion of the Board
of Directors, the Company may also match employee contributions up to an
additional 5% of an employee's salary, not to exceed $4,750 or, in aggregate,
$9,500 for a total matched contribution not to exceed 15% of an employee's
compensation.
1997 Stock Plan
Pursuant to the inTEST Corporation 1997 Stock Plan (the "Plan" or the
"1997 Stock Plan"), directors, key employees and consultants of the Company are
eligible to receive awards of (i) options to purchase shares of Common Stock
and (ii) shares of Common Stock. Options granted under the Plan may be
"incentive stock options" ("ISOs"), within the meaning of Section 422 of the
Internal Revenue Code of 1986, as amended (the "Code"), or non-qualified stock
options ("NQSOs"). Stock awards may be granted in addition to or in lieu of any
other award granted under the Plan. The Company has authorized 500,000 shares
of Common Stock for issuance upon exercise of options or stock awards under the
Plan (subject to anti-dilution and similar adjustments).
The Plan consists of two parts: the Non-Qualified Plan and the Key
Employee Plan. The Non-Qualified Plan is administered by the Board of Directors
of the Company and the Key Employee Plan is administered by the Compensation
Committee of the Board of Directors of the Company (the Board of Directors or
the Compensation Committee, as the case may be, is referred to herein as the
"Administrator").
Subject to the provisions of the Plan, the Administrator will determine
the type of award, when and to whom awards will be granted, the number of
shares covered by each award and the terms, provisions and kind of
consideration payable, if any, with respect to awards to key employees and
consultants. In determining the persons to whom awards shall be granted and the
number of shares covered by each award, the Administrator shall take into
account the duties of the respective persons, their present and potential
contribution to the success of the Company and such other factors as the
Administrator shall deem relevant. The Administrator may interpret the Plan and
may at any time adopt such rules and regulations for the Plan as it deems
advisable.
An option may be granted on such terms and conditions as the Administrator
may approve. No option may be granted with an exercise period in excess of ten
years from the date of grant. Generally, ISOs will be granted with an exercise
price equal to the "Fair Market Value" (as defined in the Plan) on the date of
grant; the exercise price of an NQSO will be determined by the Administrator.
In the case of ISOs, certain limitations will apply with respect to the
aggregate value of option shares which can become exercisable for the first
time during any one calendar year, and certain additional limitations will
apply to ISOs granted to persons who, at the time the option is granted, own
more than 10% of the combined voting power of the Company. The Administrator
may provide for the payment of the option price in cash, by delivery of Common
Stock having a Fair Market Value equal to such option price, by a combination
thereof or by any other method. Options granted under the Plan will become
exercisable at such times and under such conditions as the Administrator shall
determine, subject to acceleration of the exercisability of options in the
event of, among other things, a "Change in Control" (as defined in the Plan).
All options to the extent not earlier exercised, expire on the earliest of
(i) the last business day immediately preceding the tenth anniversary of the
date of grant, (ii) one year following the optionee's termination of his or her
employment or service with the Company (unless such termination is for cause,
as defined in the Plan, in which case any options held by such optionee will
terminate immediately) or (iii) a date set by the Administrator upon a finding
that a change in the financial accounting treatment for the options would or
may have a material adverse effect on the Company. In addition, in the event of
a change of control, as defined in the Plan, the Administrator may take
whatever actions with respect to outstanding options it deems necessary or
advisable, including accelerating the expiration date of any such outstanding
option to a date not earlier than thirty (30) days from the date notice of such
acceleration is given to the respective optionee.
34
<PAGE>
The Plan further provides for the granting of stock awards, which are
awards of Common Stock which may be subject to restrictions on the sale or
other disposition of such shares, except by will or the laws of descent and
distribution, during such period of time as the Administrator determines. The
Administrator may also impose such other conditions and restrictions, if any,
on the shares as it deems appropriate, including, for example, the continued
employment of the recipient.
The Board of Directors may at any time suspend, amend, modify or terminate
the Plan provided that, with respect to the Key Employee Plan, any amendment
which would change the eligibility of employees or a class of employees
eligible to receive an option or to increase the maximum number of shares as to
which options may be granted, will only be effective if such action is approved
by the holders of a majority of the issued and outstanding shares of Common
Stock. In addition, no change may be made which would adversely affect any
award previously granted, except with the written consent of the grantee. No
awards may be granted under the Plan more than ten years from the date the Plan
was adopted.
The Administrator has granted options to purchase 150,000 shares of Common
Stock to key employees pursuant to the Key Employee Plan. The grant of these
options will become effective on the effective date of the Registration
Statement. These options, which are ISOs, will become exercisable on a pro rata
basis annually on the first through fifth anniversaries of the effective date of
the Registration Statement. Stuart F. Daniels, Ph.D. and Hugh T. Regan, Jr. will
receive options to purchase 10,000 and 30,000 shares of Common Stock,
respectively. Dr. Daniels and Mr. Regan are the only directors or executive
officers of the Company to be granted options under the Plan to date.
Limitation of Liability and Indemnification
Pursuant to the provisions of the Delaware General Corporation Law
("DGCL"), the Company has adopted provisions in its Certificate of
Incorporation which limit the personal liability of its directors to the
Company or its stockholders for monetary damages for breach of their fiduciary
duty as a director to the fullest extent permitted by the DGCL, and in its
Bylaws which require the Company to indemnify its directors and officers to the
fullest extent permitted by Delaware law. The Bylaws require the Company to
indemnify an officer or director in connection with a proceeding (or part
thereof) initiated by such officer or director only if the initiation of such
proceeding by such person was authorized by the Board of Directors. The Company
has applied for a directors' and officers' liability insurance policy.
Compensation Committee Interlocks and Insider Participation
The Compensation Committee consists of Robert E. Matthiessen, Richard O.
Endres and Stuart F. Daniels, Ph.D. Mr. Matthiessen is the President and Chief
Operating Officer of the Company. Mr. Endres has never served as an officer or
employee of the Company. Dr. Daniels was a co-founder of the Company and served
as Vice President and Director in 1982. From 1982 until Dr. Daniels was
re-elected to the Board of Directors in April 1997, his only relationship with
the Company was as a stockholder. Prior to the offering, the Company did not
have a Compensation Committee, and compensation decisions were made by the
Board of Directors, which consisted of Messrs. Holt, Endres and Graham.
35
<PAGE>
PRINCIPAL AND SELLING STOCKHOLDERS
The following table sets forth certain information regarding the
beneficial ownership of the Company's Common Stock as of March 31, 1997 and
after giving effect to the sale of shares of Common Stock in the offering by
(i) each Director or Named Executive Officer of the Company, (ii) each person
known by the Company to own beneficially five percent or more of the Common
Stock, (iii) each Selling Stockholder and (iv) all current executive officers
and directors of the Company as a group.
<TABLE>
<CAPTION>
Prior to Offering(1) After Offering(1)(2)
----------------------------- ----------------------------
Shares Shares
Beneficially Percentage Shares Being Beneficially Percentage
Name of Beneficial Owner Owned Owned Offered(2) Owned Owned
- ------------------------------------- -------------- ------------ -------------- -------------- -----------
<S> <C> <C> <C> <C> <C>
Alyn R. Holt (3)(4)(5) ............ 2,083,217 50.9% 232,550 1,850,667 31.3%
Richard O. Endres (3)(4)(6) ......... 483,435 11.8 53,965 429,470 7.3
Daniel J. Graham (3)(4) ............ 446,729 10.9 49,868 396,861 6.7
Deed of Trust f/b/o K.D. Holt (3) . 261,727 6.4 29,216 232,511 3.9
Connie E. Holt ..................... 186,948 4.6 20,869 166,079 2.8
Robert E. Matthiessen (4) ......... 160,364 3.9 17,901 142,463 2.4
Hugh T. Regan, Sr. (4) ............ 129,098 3.2 14,411 114,687 1.9
Brian R. Moore (4) .................. 93,219 2.3 10,406 82,813 1.4
Nils O. Ny (4) ..................... 70,106 1.7 7,826 62,280 1.1
Jack R. Edmunds (4) ............... 67,459 1.6 7,530 59,929 1.0
John W. Lalley ..................... 53,905 1.3 6,017 47,888 *
Micronics Japan Company, Ltd. (7) 48,209 1.2 5,382 42,827 *
Julian P. Partington (4) ............ 45,664 1.1 5,097 40,567 *
Tomoyasu Ogura (4) .................. 43,388 1.1 4,843 38,545 *
Christopher L. West (4) ............ 42,532 1.0 4,748 37,784 *
William R. Blatchley (4) ............ 34,274 * 3,826 30,448 *
Ann L. Martz ........................ 23,369 * 2,609 20,760 *
Dale G. Holt ........................ 18,695 * 2,087 16,608 *
Jerome R. Bortnem (4) ............... 15,579 * 1,739 13,840 *
Stuart F. Daniels, Ph.D. (4) ...... 14,021 * 1,565 12,456 *
John J. Kotarski (4) ............... 9,347 * 1,043 8,304 *
Tomio Wakamatsu (4) ............... 3,214 * 359 2,855 *
Kenji Murayama (4) .................. 3,214 * 359 2,855 *
All executive officers and directors
as a group (7 persons) ............ 3,316,864 81.1% 370,260 2,946,604 49.7%
</TABLE>
- ------------
* Denotes less than 1%.
(1) Unless otherwise indicated below, the persons in the above table have sole
voting and investment power with respect to all shares owned by them.
Includes 300,443 shares of Common Stock issued in the Exchange. See "The
Company."
(2) If the Underwriters' over-allotment option is exercised in full, the
Selling Stockholders will sell an aggregate of 341,250 shares, allocated
among them in the same proportion as the relative number of shares being
offered by each of them as set forth above.
(3) The address of the stockholder is: c/o the Company, 2 Pin Oak Lane, Cherry
Hill, New Jersey 08003.
(4) The Selling Stockholder is, or was during the past three years, a director,
officer or employee of the Company.
(5) Does not include 261,727 shares held in trust for the benefit of Mr. Holt's
child or 186,948 shares owned by Mr. Holt's spouse, Connie E. Holt. Mr.
Holt disclaims beneficial ownership of the shares held in trust for his
child and the shares owned by his spouse. Includes 48,487 shares acquired
pursuant to the Exchange. See "The Company."
(6) Includes 261,727 shares held in trust for the benefit of Mr. Holt's child
for which Mr. Endres is trustee.
(7) This Selling Stockholder is a publicly owned Japanese company. inTEST KK
occupies its facility pursuant to an agreement with this Selling
Stockholder.
36
<PAGE>
DESCRIPTION OF CAPITAL STOCK
The authorized capital stock of the Company consists of 20,000,000 shares
of Common Stock and 5,000,000 shares of Preferred Stock.
The following summary of certain provisions of the Common Stock and
Preferred Stock does not purport to be complete and is subject to, and
qualified in its entirety by, the provisions of the Company's Certificate of
Incorporation that are included as an exhibit to the Registration Statement of
which this Prospectus is a part, and by the provisions of applicable law.
Common Stock
As of March 31, 1997, there were 3,790,591 shares of Common Stock
outstanding that were held of record by 17 stockholders. Prior to the offering,
the Company will issue an additional 300,443 shares of its Common Stock in
exchange for the minority interests in the Company's three subsidiaries (the
"Exchange"). Giving effect to the sale of the shares of Common Stock offered by
the Company in the offering and the shares to be issued in the Exchange, there
will be 5,911,034 shares of Common Stock outstanding immediately following the
offering.
Holders of Common Stock are entitled to one vote per share, to receive
dividends when and if declared by the Board of Directors and to share ratably
in the assets of the Company legally available for distribution to its
stockholders in the event of liquidation. Holders of Common Stock have no
preemptive, subscription, redemption or conversion rights. All outstanding
shares of Common Stock are, and the shares to be sold hereby will be, upon
issuance and payment therefor, duly authorized, fully paid and nonassessable.
The holders of Common Stock do not have cumulative voting rights. The holders
of a majority of the shares of Common Stock can elect all the directors and can
control the management and affairs of the Company. The rights, preferences and
privileges of holders of Common Stock will be subject to the rights of the
holders of any series of Preferred Stock that the Company may issue in the
future.
Preferred Stock
The Company has an authorized class of undesignated Preferred Stock
consisting of 5,000,000 shares. Preferred Stock may be issued in series from
time to time with such designations, relative rights, priorities, preferences,
qualifications, limitations and restrictions thereof, to the extent that such
are not fixed in the Company's Certificate of Incorporation, as the Board of
Directors determines. The rights, priorities, preferences, qualifications,
limitations and restrictions of different series of Preferred Stock may differ
with respect to dividend rates, amounts payable on liquidation, voting rights,
conversion rights, redemption provisions, sinking fund provisions and other
matters. The Board of Directors may authorize the issuance of Preferred Stock
which ranks senior to the Common Stock with respect to the payment of dividends
and the distribution of assets on liquidation. In addition, the Board of
Directors is authorized to fix the limitations and restrictions, if any, upon
the payment of dividends on Common Stock to be effective while any shares of
Preferred Stock are outstanding. The Board of Directors, without stockholder
approval, can issue Preferred Stock with voting and conversion rights which
could adversely affect the voting power of the holders of Common Stock. The
issuance of Preferred Stock may have the effect of delaying, deferring or
preventing a change of control of the Company. Upon consummation of the
offering, no shares of Preferred Stock will be outstanding. The Company has no
present intention to issue shares of Preferred Stock.
Certain Corporate Provisions
The Company's Certificate of Incorporation and Bylaws contain a number of
provisions relating to corporate governance and to the rights of stockholders.
Certain of these provisions may be deemed to have a potential "anti-takeover"
effect in that such provisions may delay, defer or prevent a change of control
of the Company. These provisions include the authority of the Board of
Directors to issue series of Preferred Stock with such voting rights and other
powers as the Board of Directors may determine. See "Management -- Executive
Officers, Directors and Significant Employees."
37
<PAGE>
The Company is subject to the provisions of the DGCL. Section 203 of the
DGCL prohibits a publicly-held Delaware corporation from engaging in a
"business combination" with an "interested stockholder" for a period of three
years after the date of the transaction in which the person became an
interested stockholder, unless the business combination is approved in a
prescribed manner. A "business combination" includes mergers, asset sales and
other transactions resulting in a financial benefit to the interested
stockholder. Subject to certain exceptions, an "interested stockholder" is a
person who, together with affiliates, owns, or within three years did own, 15
percent or more of the corporation's voting stock.
Transfer Agent and Registrar
The transfer agent and registrar for the Common Stock of the Company is
The First National Bank of Boston.
SHARES ELIGIBLE FOR FUTURE SALE
Prior to the offering, there has been no public market for the Common
Stock of the Company. Future sales of substantial amounts of Common Stock in
the public market could adversely affect the prevailing market prices.
Upon completion of the offering, there will be 5,911,034 shares of Common
Stock of the Company outstanding, of which 3,338,078 will be "restricted
securities" and may be publicly sold only if registered under the Securities
Act or sold in accordance with an applicable exemption from registration, such
as Rule 144.
In general, under Rule 144 as currently in effect, a stockholder,
including an "affiliate" of the Company, as that term is defined in Rule 144
(an "Affiliate"), who has beneficially owned his or her restricted securities
(as that term is defined in Rule 144) for at least one year from the later of
the date such securities were acquired from the Company or (if applicable) the
date they were acquired from an Affiliate, is entitled to sell, within any
three-month period, a number of such shares that does not exceed the greater of
one percent of the then outstanding shares of Common Stock (approximately
59,110 shares immediately after the offering) or the average weekly trading
volume in the Common Stock during the four calendar weeks preceding the date on
which notice of such sale was filed under Rule 144, provided certain
requirements concerning availability of public information, manner of sale and
notice of sale are satisfied. In addition, under Rule 144(k), if a period of at
least two years has elapsed between the later of the date restricted securities
were acquired from the Company and the date they were acquired from an
Affiliate of the Company, a stockholder who is not an Affiliate of the Company
at the time of sale and has not been an Affiliate for at least three months
prior to the sale would be entitled to sell the shares immediately without
compliance with the foregoing requirements under Rule 144.
As of the date of this Prospectus, the Company and each of its
stockholders have agreed that they will not directly or indirectly, offer,
sell, offer to sell, grant any option to purchase or otherwise sell or dispose
(or approve any offer, sale, offer of sale, grant of any options to purchase or
sale or disposition) of any shares of Common Stock or other capital stock of
the Company, or any securities convertible into, or exercisable or exchangeable
for, any shares of Common Stock or other capital stock of the Company without
the prior written consent of Janney Montgomery Scott Inc., on behalf of the
Underwriters, for a period of 180 days from the date of this Prospectus (the
"Lock-up Agreements"). Notwithstanding the foregoing, Mr. Holt reserved the
right to make a charitable contribution of up to 100,000 shares of Common Stock
which would not be subject to the lock-up agreement. Beginning 180 days after
the date of this Prospectus, approximately 297,841 shares of Common Stock will
become eligible for resale without volume or other limitations pursuant to Rule
144.
An additional 500,000 shares of Common Stock in the aggregate are reserved
for future issuance under the 1997 Stock Plan, and options to purchase a total
of 150,000 shares have been granted which will become effective as of the
effective date of the Registration Statement. The Company intends to file a
registration statement under the Act shortly after the effective date of the
Registration Statement, covering certain shares of Common Stock reserved for
issuance under the 1997 Stock Plan. Upon the effectiveness of that registration
statement, most of the shares of Common Stock which may be issued pursuant to
the 1997 Stock Plan, other than shares held by Affiliates, will be immediately
eligible for resale in the public market without restriction, subject to the
terms of the Lock-up Agreements, if applicable. See "Management -- 1997 Stock
Plan."
38
<PAGE>
UNDERWRITING
The Underwriters named below, acting through their Representatives, Janney
Montgomery Scott Inc. and Needham & Company, Inc. have severally agreed,
subject to the terms and conditions of the Underwriting Agreement, to purchase
a total of 1,820,000 shares of Common Stock from the Company and 455,000 shares
of Common Stock from the Selling Stockholders. The number of shares of Common
Stock that each Underwriter has agreed to purchase is set forth opposite its
name below. The Underwriters are committed to purchase all of such shares if
any are purchased. Under certain circumstances, the commitments of
non-defaulting Underwriters may be increased. The names of the several
Underwriters and the respective number of shares to be purchased by each of
them are as follows:
Number of
Underwriter Shares
- ----------- ----------
Janney Montgomery Scott Inc. ......
Needham & Company, Inc. ............
----------
Total .............................. 2,275,000
==========
The Company is obligated to sell, and the Underwriters are obligated to
purchase, all of the shares of Common Stock offered hereby if any are
purchased.
The Underwriters, through their Representatives, have advised the Company
and the Selling Stockholders: that they propose to offer the Common Stock
initially at the public offering price set forth on the cover page of this
Prospectus; that the Underwriters may allow to selected dealers a concession of
$ per share; and that such dealers may reallow a concession of $ per
share to certain other dealers. After the initial public offering, the offering
price and the concessions may be changed by the Representatives.
The Selling Stockholders have granted to the Underwriters an option,
exercisable for 30 days from the date of this Prospectus, to purchase up to
341,250 additional shares of Common Stock at the initial public offering price,
less underwriting discounts and commissions, as set forth on the cover page of
this Prospectus. The Underwriters may exercise such option solely for the
purpose of covering over-allotments incurred in the sale of the shares of
Common Stock offered hereby. To the extent such option to purchase is
exercised, each Underwriter will become obligated, subject to certain
conditions, to purchase approximately the same percentage of such additional
shares as the number set forth next to such Underwriter's name in the preceding
table bears to 2,275,000.
The Company and the Selling Stockholders have agreed to indemnify the
several Underwriters or contribute to losses arising out of certain
liabilities, including liabilities under the Securities Act.
As of the date of this Prospectus, the Company, its officers and
directors, and stockholders of the Company holding 3,636,034 shares of Common
Stock upon completion of the offering, have agreed that they will not, directly
or indirectly, offer, sell, offer to sell, grant any option to purchase or
otherwise sell or dispose (or approve any offer, sale, offer of sale, grant of
any options to purchase or sale or disposition) of any shares of Common Stock
or other capital stock of the Company or any securities convertible into, or
exercisable or exchangeable for, any shares of Common Stock or other capital
stock of the Company without the prior written consent of Janney Montgomery
Scott Inc., for a period of 180 days from the date of this Prospectus.
Notwithstanding the foregoing, Mr. Holt reserved the right to make a charitable
contribution of up to 100,000 shares of Common Stock which would not be subject
to the lock-up agreement. See "Shares Eligible for Future Sale."
The Representatives have informed the Company that the Underwriters do not
intend to confirm sales to any accounts over which they exercise discretionary
authority.
Prior to the offering, there has been no public market for the Common
Stock of the Company. Consequently, the initial public offering price will be
determined through negotiations among the Company and the Representatives.
Among the factors considered in making such determination are the prevailing
market conditions, the Company's financial and operating history and condition,
its prospects and the prospects for its industry in general, the management of
the Company, and the market prices of securities for companies in businesses
similar to that of the Company.
39
<PAGE>
LEGAL MATTERS
The legality of the issuance of the shares of Common Stock being offered
hereby will be passed upon for the Company and the Selling Stockholders by
Saul, Ewing, Remick & Saul, Philadelphia, Pennsylvania. Certain legal matters
in connection with patent law matters will be passed upon for the Company by
Ratner & Prestia, Berwyn, Pennsylvania. Certain legal matters will be passed
upon for the Underwriters by Pepper, Hamilton & Scheetz LLP, Philadelphia,
Pennsylvania.
EXPERTS
The Consolidated Financial Statements of the Company as of December 31,
1996 and 1995 and for each of the years in the three-year period ended December
31, 1996, have been included herein and in the Registration Statement in
reliance upon the report of KPMG Peat Marwick LLP, independent certified public
accountants, appearing elsewhere herein, and upon the authority of said firm as
experts in accounting and auditing.
Certain matters dealing with patents and proprietary rights set forth
under "Risk Factors -- Importance of Patents and Proprietary Rights; Risk of
Litigation," "Business -- Strategy -- Capitalize on Experience and Expertise"
and "Business -- Patents and Other Proprietary Rights" have been included in
this Prospectus in reliance upon the written opinion of Ratner & Prestia,
Berwyn, Pennsylvania, patent counsel for the Company, as experts in such
matters.
ADDITIONAL INFORMATION
The Company is not currently subject to the information requirements of
the Securities Exchange Act of 1934, as amended (the "Exchange Act"). As a
result of the offering, the Company will be required to file reports and other
information with the Securities and Exchange Commission (the "Commission")
pursuant to the informational requirements of the Exchange Act.
The Company has filed with the Commission a Registration Statement on Form
S-1 under the Act with respect to the Common Stock offered hereby. This
Prospectus does not contain all of the information set forth in the
Registration Statement and the exhibits and schedules thereto. Statements
contained in this Prospectus as to the contents of any contract or other
document referred to are not necessarily complete and in each instance
reference is made to the copy of such contract or other document filed as an
exhibit to the Registration Statement, each such statement being qualified in
all respects by such reference. For further information, reference is made to
the Registration Statement and exhibits thereto. The Registration Statement may
be inspected without charge at the Office of the Commission at 450 Fifth
Street, N.W., Washington, D.C. 20549. Copies of the Registration Statement may
be obtained from the Commission at prescribed rates from the Public Reference
Section of the Commission at such address, and at the Commission's regional
offices located at 7 World Trade Center, Suite 1300, New York, New York 10048,
and at Citicorp Center, 500 West Madison Street, Suite 1400, Chicago, Illinois
60661-2511. In addition, registration statements and certain other filings made
with the Commission through its Electronic Data Gathering, Analysis, and
Retrieval ("EDGAR") system are publicly available through the Commission's site
on the Internet's World Wide Web, located at http://www.sec.gov. The
Registration Statement, including all exhibits thereto and amendments thereof,
has been filed with the Commission through EDGAR.
The Company intends to furnish to its stockholders annual reports
containing financial statements audited by an independent accounting firm.
40
<PAGE>
inTEST CORPORATION
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
Page
-----
Report of KPMG Peat Marwick LLP, Independent Auditors ...... F-2
Consolidated Financial Statements:
Consolidated Balance Sheets .............................. F-3
Consolidated Statements of Earnings ..................... F-4
Consolidated Statements of Stockholders' Equity ......... F-5
Consolidated Statements of Cash Flows ..................... F-6
Notes to Consolidated Financial Statements ............... F-7
F-1
<PAGE>
Independent Auditors' Report
The Board of Directors and Stockholders
inTEST Corporation and Subsidiaries:
We have audited the accompanying consolidated balance sheets of inTEST
Corporation and subsidiaries as of December 31, 1995 and 1996, and the related
consolidated statements of earnings, stockholders' equity, and cash flows for
each of the years in the three-year period ended December 31, 1996. These
consolidated financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on these consolidated
financial statements based on our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of
material misstatement. An audit includes examining, on a test basis, evidence
supporting the amounts and disclosures in the financial statements. An audit
also includes assessing the accounting principles used and significant
estimates made by management, as well as evaluating the overall financial
statement presentation. We believe that our audits provide a reasonable basis
for our opinion.
In our opinion, the consolidated financial statements referred to above present
fairly, in all material respects, the financial position of inTEST Corporation
and subsidiaries at December 31, 1995 and 1996, and the results of their
operations and their cash flows for each of the years in the three-year period
ended December 31, 1996, in conformity with generally accepted accounting
principles.
/s/ KPMG Peat Marwick LLP
Philadelphia, Pennsylvania
March 14, 1997, except for the first two paragraphs of
Note 12, as to which the date is April 25, 1997, and
the third paragraph of Note 12, as to which the
date is June 4, 1997
F-2
<PAGE>
inTEST CORPORATION AND SUBSIDIARIES
Consolidated Balance Sheets
(in thousands, except for share data)
<TABLE>
<CAPTION>
December 31, March 31, 1997
--------------------- ----------------------------
Pro forma
Actual (Note 3)
1995 1996 (unaudited) (unaudited)
--------- --------- ------------- ------------
<S> <C> <C> <C> <C>
Current assets:
Cash and cash equivalents ........................ $ 1,919 $ 3,692 $ 2,983 $ 2,983
Trade accounts and notes receivable, net of
allowance for doubtful accounts of $42 at
December 31, 1995 and $88 at December 31,
1996 and March 31, 1997 ........................... 2,992 1,953 2,495 2,495
Inventories ....................................... 1,218 1,313 1,178 1,178
Deferred tax asset ................................. -- -- -- 56
Other current assets .............................. 11 70 167 167
-------- ------- ------- -------
Total current assets .............................. 6,140 7,028 6,823 6,879
-------- ------- ------- -------
Property and equipment:
Machinery and equipment ........................... 633 1,096 1,082 1,082
Leasehold improvements ........................... 55 173 169 169
-------- ------- ------- -------
688 1,269 1,251 1,251
Accumulated depreciation ........................... (547) (676) (701) (701)
-------- ------- ------- -------
Net property and equipment ........................ 141 593 550 550
-------- ------- ------- -------
Other assets ....................................... 71 95 119 119
Goodwill (Note 3) .................................... -- -- -- 1,508
-------- ------- ------- -------
Total assets ....................................... $ 6,352 $ 7,716 $ 7,492 $ 9,056
======== ======= ======= =======
Current liabilities:
Current installments of long term debt ............ $ -- $ 34 $ 34 $ 34
Accounts payable ................................. 845 574 837 837
Dividends payable ................................. -- 973 1,216 1,216
Accrued wages and expenses ........................ 299 595 427 427
Customer deposits ................................. 191 -- -- --
State and foreign income taxes payable ............ 604 475 385 385
S corporation distribution to stockholders (Note 3) -- -- -- 3,420
-------- ------- ------- -------
Total current liabilities ........................... 1,939 2,651 2,899 6,319
-------- ------- ------- -------
Long term debt .................................... -- 155 148 148
Deferred tax liability .............................. -- -- -- 8
Minority interest ................................. 365 323 291 --
-------- ------- ------- -------
Commitments (Note 8)
Stockholders' equity:
Preferred stock, $0.01 par value; 5,000,000 shares
authorized; no shares issued or outstanding ...... -- -- -- --
Common stock, $0.01 par value; 20,000,000
shares authorized; 3,790,591 shares issued and
outstanding at December 31, 1995 and 1996 and
March 31, 1997; 4,091,034 shares issued and
outstanding pro forma ........................... 38 38 38 41
Additional paid-in capital ........................ 689 689 689 2,574
Retained earnings ................................. 3,273 3,833 3,461 --
Foreign currency translation adjustment ............ 48 27 (34) (34)
-------- ------- ------- -------
Total stockholders' equity ........................ 4,048 4,587 4,154 2,581
-------- ------- ------- -------
Total liabilities and stockholders' equity ......... $ 6,352 $ 7,716 $ 7,492 $ 9,056
======== ======= ======= =======
</TABLE>
See accompanying Notes to Consolidated Financial Statements.
F-3
<PAGE>
inTEST CORPORATION AND SUBSIDIARIES
Consolidated Statements of Earnings
(in thousands, except for per share data)
<TABLE>
<CAPTION>
Three months ended
Years ended December 31, March 31,
---------------------------------- ----------------------------
1996 1997
1994 1995 1996 (unaudited) (unaudited)
--------- --------- ---------- ------------- ------------
<S> <C> <C> <C> <C> <C>
Revenues .......................................... $ 9,287 $ 14,442 $ 18,582 $ 6,089 $ 3,887
Cost of revenues .................................... 3,777 5,191 6,755 1,856 1,602
-------- -------- -------- -------- --------
Gross profit ....................................... 5,510 9,251 11,827 4,233 2,285
-------- -------- -------- -------- --------
Operating expenses:
Selling expense .................................... 1,491 2,118 2,471 781 493
Research and development expense .................. 1,623 1,930 1,928 394 374
General and administrative expense ............... 1,107 1,166 1,812 364 411
-------- -------- -------- -------- --------
Total operating expenses ........................... 4,221 5,214 6,211 1,539 1,278
-------- -------- -------- -------- --------
Operating income .................................... 1,289 4,037 5,616 2,694 1,007
-------- -------- -------- -------- --------
Other income (expense):
Interest income .................................... 22 82 147 23 29
Interest expense ................................. (9) -- (11) (5) (4)
Other ............................................. 24 (49) (35) (6) (10)
-------- -------- -------- -------- --------
37 33 101 12 15
-------- -------- -------- -------- --------
Earnings before income taxes and minority interest ... 1,326 4,070 5,717 2,706 1,022
-------- -------- -------- -------- --------
Provision for income taxes:
State ............................................. 9 82 126 75 21
Foreign .......................................... 373 555 732 280 146
-------- -------- -------- -------- --------
Income tax expense ................................. 382 637 858 355 167
-------- -------- -------- -------- --------
Earnings before minority interest .................. 944 3,433 4,859 2,351 855
Minority interest ................................. (127) (181) (213) (94) (11)
-------- -------- -------- -------- --------
Net earnings ....................................... $ 817 $ 3,252 $ 4,646 $ 2,257 $ 844
======== ======== ======== ======== ========
Pro forma information (unaudited) (Note 3):
Pro forma earnings before income taxes ............ $ -- $ -- $ 5,616 $ -- $ 997
Pro forma income taxes .............................. -- -- 2,246 -- 459
Pro forma net earnings ........................... -- -- 3,370 -- 538
Pro forma net earnings per share .................. $ -- $ -- $ 0.82 $ -- $ 0.13
Pro forma weighted average shares outstanding ...... -- -- 4,091 -- 4,091
Supplemental pro forma net earnings per share ...... $ -- $ -- $ 0.79 -- $ 0.13
Supplemental pro forma weighted average shares
outstanding ....................................... -- -- 4,291 -- 4,291
======== ======== ======== ======== ========
</TABLE>
See accompanying Notes to Consolidated Financial Statements.
F-4
<PAGE>
inTEST CORPORATION AND SUBSIDIARIES
Consolidated Statement of Stockholders' Equity
(in thousands, except for share data)
<TABLE>
<CAPTION>
Foreign
Common Stock Additional currency Total stock-
---------------------- paid-in Retained translation holders'
Shares Amount capital earnings adjustment equity
----------- -------- ------------ ---------- ------------- -------------
<S> <C> <C> <C> <C> <C> <C>
Balance, January 1, 1994 .................. 3,720,486 $37 $639 $ 1,821 $ (49) $ 2,448
Dividends ................................. -- -- -- (642) -- (642)
Net earnings .............................. -- -- -- 817 -- 817
Shares issued as compensation for
services ................................. 7,789 -- 5 -- -- 5
Foreign currency translation adjustment..... -- -- -- -- 137 137
---------- ---- ----- -------- ------ --------
Balance, December 31, 1994 ............... 3,728,275 37 644 1,996 88 2,765
Dividends ................................. -- -- -- (1,975) -- (1,975)
Net earnings .............................. -- -- -- 3,252 -- 3,252
Shares issued as compensation for
services ................................. 62,316 1 45 -- -- 46
Foreign currency translation adjustment..... -- -- -- -- (40) (40)
---------- ---- ----- -------- ------ --------
Balance, December 31, 1995 ............... 3,790,591 38 689 3,273 48 4,048
Dividends ................................. -- -- -- (4,086) -- (4,086)
Net earnings .............................. -- -- -- 4,646 -- 4,646
Foreign currency translation adjustment..... -- -- -- -- (21) (21)
---------- ---- ----- -------- ------ --------
Balance, December 31, 1996 ............... 3,790,591 38 689 3,833 27 4,587
Dividends (unaudited) ..................... -- -- -- (1,216) -- (1,216)
Net earnings (unaudited) .................. -- -- -- 844 -- 844
Foreign currency translation adjustment
(unaudited) .............................. -- -- -- -- (61) (61)
---------- ---- ----- -------- ------ --------
Balance, March 31, 1997 (unaudited) ........ 3,790,591 $38 $689 $ 3,461 $ (34) $ 4,154
========== ==== ===== ======== ====== ========
</TABLE>
See accompanying Notes to Consolidated Financial Statements.
F-5
<PAGE>
inTEST CORPORATION AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(in thousands of dollars)
<TABLE>
<CAPTION>
Three months ended
Years ended December 31, March 31,
--------------------------------- ---------------------------
1994 1995 1996 1996 1997
--------- ---------- ---------- ------------- ------------
(unaudited) (unaudited)
<S> <C> <C> <C> <C> <C>
Cash flows from operating activities:
Net earnings .................................... $ 817 $ 3,252 $ 4,646 $ 2,257 $ 844
Adjustments to reconcile net earnings to net cash
Depreciation and amortization .................. 59 36 109 11 41
Foreign exchange (gain) loss .................. (25) 43 31 (3) (3)
Minority interest .............................. 127 181 213 94 11
Stock issued for services received ............ 5 46 -- -- --
Changes in assets and liabilities:
Accounts receivable ........................ (544) (850) 1,182 (1,321) (684)
Inventories ................................. 58 (284) (66) (80) 97
Other current assets ........................ (4) (46) (61) (56) (123)
Notes receivable ........................... (68) (170) (216) 100 42
Accounts payable ........................... 203 342 (235) 753 307
State and foreign income tax payable ......... 249 261 (118) (105) (72)
Accrued expenses ........................... 54 35 50 204 (129)
Other assets ................................. 45 (101) (65) -- --
------- -------- -------- -------- --------
Total adjustments .............................. 159 (507) 824 (403) (513)
------- -------- -------- -------- --------
Net cash provided by operations .................. 976 2,745 5,470 1,854 331
------- -------- -------- -------- --------
Cash flows used in investing activities:
Purchase of property and equipment ............ (38) (39) (554) (13) (5)
------- -------- -------- -------- --------
Net cash used in investing activities ............ (38) (39) (554) (13) (5)
------- -------- -------- -------- --------
Cash flows used in financing activities:
Dividends paid ................................. (642) (1,976) (3,339) (186) (1,001)
Proceeds from long term debt .................. -- -- 200 -- --
Principal payments on debt ..................... (71) (8) (11) -- (8)
------- -------- -------- -------- --------
Net cash used in financing activities ............ (713) (1,984) (3,150) (186) (1,009)
------- -------- -------- -------- --------
Effects of exchange rates on cash ............... 77 (139) 7 (6) (26)
------- -------- -------- -------- --------
Net cash provided by all activities ............ 302 583 1,773 1,649 (709)
Cash at beginning of period .................. 1,034 1,336 1,919 1,919 3,692
------- -------- -------- -------- --------
Cash at end of period ........................ $ 1,336 $ 1,919 $ 3,692 $ 3,568 $ 2,983
======= ======== ======== ======== ========
Cash payments made for:
State and foreign income taxes .................. $ 122 $ 374 $ 977 $ 471 $ 241
Interest ....................................... 13 9 11 5 4
</TABLE>
See accompanying Notes to Consolidated Financial Statements.
F-6
<PAGE>
inTEST CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements
(Information as of March 31, 1997 and for the three months ended
March 31, 1996 and 1997 is unaudited)
(in thousands, except for share data)
(1) Nature of Operations
inTEST Corporation ("the Company") designs, manufactures and markets
docking hardware and test head manipulators used by semiconductor manufacturers
during the testing of wafers and packaged devices. The Company also designs and
markets related automatic test equipment interface products. The Company
operates in a single industry segment.
The consolidated entity is comprised of inTEST Corporation (parent) and
three 79% owned foreign subsidiaries: inTEST Limited (Thame, U.K.), inTEST
Kabushiki Kaisha (Kichijoji, Japan) and inTEST PTE, Limited (Singapore). All
significant intercompany accounts and transactions have been eliminated upon
consolidation.
inTEST manufactures its products in the U.S. and the U.K. Its subsidiaries
in Singapore and Japan are engaged in marketing and support activities.
(2) Summary of Significant Accounting Policies
Use of Estimates
The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents
Short term investments, which have maturities of three months or less when
purchased, are considered to be cash equivalents and are carried at cost, which
approximates market value.
Notes Receivable
Notes receivable are due from trade customers, and have original
maturities of less than three months. The notes are non-interest bearing.
Inventories
Inventories are stated at lower of cost or market. Cost is determined
under the first-in first-out (FIFO) method.
Property and Equipment
Machinery and equipment are stated at cost. Depreciation is based upon the
estimated useful life of the assets using the straight line method. The
estimated useful lives range from five to seven years. Leasehold improvements
are recorded at cost and amortized over the shorter of the lease term or
estimated useful life of the asset. Expenditures for maintenance and repairs
are charged to operations as incurred.
Income Taxes
The Company has elected S corporation status for Federal tax purposes, and
in the State of New Jersey. As a result, any Federal and certain New Jersey
state income tax liabilities are that of the stockholders, not of the Company.
The Company is, however, taxed in foreign countries and for activity in certain
states.
No foreign or state deferred income taxes have been recorded in the
Company's historical financial statements at December 31, 1995 and 1996 as such
amounts are not significant.
F-7
<PAGE>
inTEST CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements
(Information as of March 31, 1997 and for the three months ended
March 31, 1996 and 1997 is unaudited)
(in thousands, except for share data)
(2) Summary of Significant Accounting Policies -- (Continued)
Revenue Recognition
Revenues from sales of products are recognized upon shipment to customers.
Research and Development
Research and development costs are expensed as incurred.
Product Warranties
The Company generally provides product warranties and records estimated
warranty expense at time of sale based upon historical claims experience.
Foreign Currency
The accounts of the foreign subsidiaries are translated in accordance with
Statement of Financial Accounting Standard No. 52, Foreign Currency
Translation, which requires that assets and liabilities of international
operations be translated using the exchange rate in effect at the balance sheet
date. The results of operations are translated using an average exchange rate
for the year. The effects of rate fluctuations in translating assets and
liabilities of international operations into U.S. dollars are accumulated and
reflected as a foreign currency translation adjustment in the statements of
stockholders' equity. Transaction gains and losses are included in net
earnings.
Recently Adopted Accounting Standards
The Company adopted the provisions of SFAS No. 121, Accounting for the
Impairment of Long-Lived Assets and for Long-Lived Assets to Be Disposed Of, on
January 1, 1996. This Statement requires that long-lived assets and certain
identifiable intangibles be reviewed for impairment whenever events or changes
in circumstances indicate that the carrying amount of an asset may not be
recoverable. Adoption of this Statement had no impact on the Company's
financial position, results of operations, or liquidity.
(3) Pro forma Information (Unaudited)
Background
In connection with the initial public offering transaction described in
Note 12, the Company plans to terminate its S corporation status and make a
final distribution of previously taxed earnings to its stockholders. In
addition, the Company intends to acquire the minority interest ownership
position in its three foreign subsidiaries in a share exchange transaction.
Accordingly, the accompanying financial statements include certain pro forma
information which gives effect to these events as further explained below.
Pro forma Balance Sheet
The pro forma balance sheet of the Company as of March 31, 1997 reflects:
a) the estimated net deferred income taxes of $48 which will be recorded
by the Company as a result of the termination of its S corporation
status shortly before the closing of the offering.
b) an estimated distribution of $3,420 payable to the stockholders of all
taxed but undistributed S corporation earnings.
F-8
<PAGE>
inTEST CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements
(Information as of March 31, 1997 and for the three months ended
March 31, 1996 and 1997 is unaudited)
(in thousands, except for share data)
(3) Pro forma Information (Unaudited) -- (Continued)
c) the acquisition of the minority interests in the Company's foreign
subsidiaries expected to occur concurrent with the closing of the
offering, and the estimated goodwill of $1,508 associated with such
acquisitions.
The Company expects to issue 300,443 shares of common stock in exchange
for the 21% interest in each of its foreign subsidiaries which is not presently
owned by the Company. The shares, exclusive of those to be issued to the
Company's principal stockholder who is also a stockholder of two of the foreign
subsidiaries, have been valued at the assumed initial public offering price of
$8.25 per share to the extent such shares are freely transferable.
Approximately 225,000 of the shares being exchanged are subject to contractual
and legal restrictions on transfer and have been valued at a 15% discount to
the assumed initial public offering price.
The deferred income tax asset will represent the tax effect of the
cumulative differences between the financial reporting and income tax bases of
certain assets and liabilities as of the termination of the S corporation
status.
The significant items comprising the Company's pro forma net deferred
income tax assets and liabilities as of March 31, 1997 are temporary
differences relating to the following:
Allowance for bad debts ......... $ 32
Inventory capitalized costs ...... 2
Accrued expenses .................. 22
-----
Current deferred tax asset ......... 56
Fixed assets ..................... (8)
-----
Net deferred tax asset ............ $ 48
=====
Since the Company does not intend to repatriate the earnings of its
foreign subsidiaries, no deferred taxes have been recorded on such amounts,
which approximate $975 at March 31, 1997.
Pro forma Statement of Earnings Information
Shortly before the closing of the offering, the Company will terminate its
status as an S corporation and will be subject to Federal and additional state
income taxes thereafter. Accordingly, for informational purposes, the statement
of earnings for the year ended December 31, 1996 and the quarter ended March
31, 1997 reflects pro forma earnings on an after-tax basis, assuming the
Company had been taxed as a C corporation. The difference between the Federal
statutory income tax rate and the pro forma income tax rate was as follows:
<TABLE>
<CAPTION>
Year ended Three months ended
December 31, 1996 March 31, 1997
------------------- -------------------
<S> <C> <C>
Federal statutory tax rate ............... 34% 34%
State income taxes, net of Federal benefit 3 3
Foreign income taxes ..................... 3 7
Nondeductible goodwill amortization ...... 1 1
Research credits ........................ (1) --
Other .................................... -- 1
---- ----
Pro forma income tax rate ............... 40% 46%
==== ====
</TABLE>
F-9
<PAGE>
inTEST CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements
(Information as of March 31, 1997 and for the three months ended
March 31, 1996 and 1997 is unaudited)
(in thousands, except for share data)
(3) Pro forma Information (Unaudited) -- (Continued)
In addition, the unaudited pro forma results for the year ended December
31, 1996 and the quarter ended March 31, 1997 also reflect goodwill
amortization resulting from the acquisition of minority interests in foreign
subsidiaries, net of the elimination of the minority interest charge reflected
in the historical financial statements, as if the acquisition had occurred on
January 1, 1996. The goodwill resulting from the acquisition is assumed to be
amortized over 15 years.
Pro forma Net Earnings Per Share
Pro forma net earnings per share was calculated by dividing pro forma net
earnings by the weighted average number of shares of common stock outstanding
during the period, adjusted to give effect to shares to be exchanged to acquire
the minority interests in foreign subsidiaries as if this transaction had
occurred on January 1, 1996.
Supplemental Pro forma Net Earnings Per Share
Supplemental pro forma net earnings per share is based on the weighted
average number of shares of common stock used in the calculation of pro forma
net earnings per share plus the number of shares that would be required to be
sold to fund certain distributions to the Company's current stockholders of
previously taxed but undistributed S corporation earnings, net of available
cash and cash equivalents (the amount of such net proceeds assumed to be used
for this purpose is estimated to be $1,653 at March 31, 1997).
(4) Foreign Operations
The Company operates in a single business segment. However, foreign
operations represent a significant portion of the Company's activity. The
following is a summary of operations by entities located within the indicated
geographic areas:
<TABLE>
<CAPTION>
Three months ended
Years ended December 31, March 31,
--------------------------------- --------------------
1994 1995 1996 1996 1997
--------- --------- --------- --------- --------
<S> <C> <C> <C> <C> <C>
Sales to unaffiliated customers from:
North America ..................... $ 4,299 $ 7,409 $10,614 $ 3,672 $ 2,433
Far East ........................... 2,560 4,862 4,860 1,359 1,108
United Kingdom ..................... 2,428 2,171 3,108 1,058 346
-------- -------- -------- -------- --------
$ 9,287 $14,442 $18,582 $ 6,089 $ 3,887
======== ======== ======== ======== ========
Affiliate sales or transfers from:
North America ........................ $ 1,000 $ 1,596 $ 1,321 $ 559 $ 81
Far East ........................... -- -- -- -- --
United Kingdom ..................... -- 451 54 48 50
-------- -------- -------- -------- --------
$ 1,000 $ 2,047 $ 1,375 $ 607 $ 131
======== ======== ======== ======== ========
Operating profit:
North America ........................ $ 338 $ 2,610 $ 3,815 $ 1,932 $ 790
Far East ........................... 182 612 432 187 66
United Kingdom ..................... 769 815 1,369 575 151
-------- -------- -------- -------- --------
$ 1,289 $ 4,037 $ 5,616 $ 2,694 $ 1,007
======== ======== ======== ======== ========
Identifiable assets:
North America ..................... $ 1,920 $ 3,327 $ 5,408 $ 5,561 $ 4,974
Far East ........................... 1,088 1,408 1,409 1,752 1,536
United Kingdom ..................... 1,616 1,617 899 1,711 982
-------- -------- -------- -------- --------
$ 4,624 $ 6,352 $ 7,716 $ 9,024 $ 7,492
======== ======== ======== ======== ========
</TABLE>
F-10
<PAGE>
inTEST CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements
(Information as of March 31, 1997 and for the three months ended
March 31, 1996 and 1997 is unaudited)
(in thousands, except for share data)
(4) Foreign Operations -- (Continued)
Amounts for the Far East consist of activities in the Company's Singapore
and Japan subsidiaries.
Export sales from the Company's New Jersey location totaled $591, $2,777,
and $3,486 during the years ended December 31, 1994, 1995, and 1996,
respectively, and $1,528 and $196 during the three months ended March 31, 1996
and 1997, respectively.
The Company's foreign subsidiaries paid directors fees to several
individuals who are members of management of the parent company which totaled
$49, $151, and $192 during the years ended December 31, 1994, 1995, and 1996,
respectively.
(5) Concentrations of Credit Risk
The Company's customers are in the semiconductor industry. During 1994,
1995, and 1996 the Company had sales to certain customers which exceeded 10% of
the Company's consolidated revenues. Those sales were as follows:
Customer 1994 1995 1996
----------- ------ ------ -----
A ......... 7% 16% 16%
B ......... 12 3 9
C ......... 14 11 8
D ......... 16 12 7
Additionally, at December 31, 1996, these four customers accounted for 27%
of trade receivables.
(6) Inventories
Inventories held at December 31 were comprised of the following:
1995 1996
--------- -------
Raw materials ............. $1,075 $1,145
Work in process ........... 20 44
Finished goods ............ 123 124
------ ------
$1,218 $1,313
====== ======
(7) Debt
In 1996, the Company financed a purchase of equipment with a term note.
The note bears interest at a fixed rate of 8.65%, and is to be paid in equal
monthly installments of $4 through August, 2001. At December 31, 1996, $189 was
outstanding. Prior to 1996 the Company had no long term debt.
Principal payments due within the next five years are as follows:
1997 ........................ $ 34
1998 ........................ 37
1999 ........................ 40
2000 ........................ 44
2001 ........................ 34
Additionally, the Company has a $1,500 line of credit. Borrowings under
this line of credit are principally used for working capital purposes.
Borrowings on the line of credit bear interest at prime rate, which is payable
monthly on any outstanding balance. Further, the Company is required to
maintain a $50 compensating balance at the bank which granted the line of
credit. The credit line expires on June 30, 1997. At December 31, 1996 and
March 31, 1997, there were no borrowings outstanding.
F-11
<PAGE>
inTEST CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements
(Information as of March 31, 1997 and for the three months ended
March 31, 1996 and 1997 is unaudited)
(in thousands, except for share data)
(8) Commitments
The Company leases its offices, warehouse facilities and automobiles under
noncancelable operating leases which expire at various dates through 2003.
Total rental expense for the years ended December 31, 1994, 1995, and 1996, and
the three months ended March 31, 1996 and 1997 was $336, $388, and $422, $83,
and $115, respectively. The aggregate minimum rental commitments under the
noncancelable operating leases in effect at December 31, 1996 are as follows:
1997 ..................... $ 346
1998 ..................... 309
1999 ..................... 275
2000 ..................... 217
2001 and thereafter ...... 452
(9) Income Taxes
As discussed in Notes 2 and 3, the Company has elected S corporation
status for Federal tax purposes, as well as certain states, and therefore is
not subject to federal income taxes directly. For those states and foreign
jurisdictions in which the Company is subject to taxes, the temporary
differences that give rise to deferred tax assets and liabilities were not
significant at December 31, 1995 and 1996, or March 31, 1997.
Earnings before income taxes were as follows:
Three months ended
Years ended December 31, March 31,
------------------------------- ------------------
1994 1995 1996 1996 1997
--------- -------- -------- -------- -------
Domestic ...... $ 345 $2,651 $3,979 $1,984 $ 835
Foreign ...... 981 1,419 1,738 722 187
-------- ------- ------- ------- -------
$ 1,326 $4,070 $5,717 $2,706 $1,022
======== ======= ======= ======= =======
Income tax expense was as follows:
Three months
ended
Years ended December 31, March 31,
------------------------ --------------
1994 1995 1996 1996 1997
------ ------ ------ ------ -----
Domestic ...... $ 9 $ 82 $126 $ 75 $ 21
Foreign ...... 373 555 732 280 146
----- ----- ----- ----- -----
$382 $637 $858 $355 $167
===== ===== ===== ===== =====
(10) Employee Benefit Plans
In 1996, the Company instituted a defined contribution 401(k) plan for its
employees who work in the U.S. All employees of the parent company who are at
least 18 years of age and have completed six months of service with the Company
are eligible to participate in the plan. Under the plan, the Company matches
employee contributions dollar for dollar up to 10% of the employee's annual
compensation up to $5. In addition, the Company may match employee
contributions dollar for dollar for amounts exceeding 15% of the employee's
annual compensation to a maximum of $5. Employer contributions vest over a
six-year period. The Company contributions in 1996 totaled $71.
F-12
<PAGE>
inTEST CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements
(Information as of March 31, 1997 and for the three months ended
March 31, 1996 and 1997 is unaudited)
(in thousands, except for share data)
(10) Employee Benefit Plans -- (Continued)
The Company sponsors a noncontributory pension plan for an employee of its
U.K. subsidiary. The Company has no other defined contribution or defined
benefit plans.
(11) Accrued Expense
Accrued wages and expenses consist of the following:
December 31, March 31,
---------------- ---------
1995 1996 1997
------- ------ ---------
Accrued commissions ...... $ 113 $390 $107
Accrued vacation ......... 101 101 101
Other ..................... 85 104 219
------ ----- -----
$ 299 $595 $427
====== ===== =====
(12) Subsequent Events
In April 1997, the Company's Board of Directors authorized the filing of a
Registration Statement on Form S-1 in connection with a planned initial public
offering of the Company's common stock.
Also in April 1997, the Company's Board of Directors reserved 500,000
shares of common stock for issuance under a newly created stock plan and also
approved the award of stock options to employees to purchase a total of 150,000
shares of common stock. The grants are to become effective on the effective
date of the Registration Statement and the options will be exercisable at a per
share price equal to the initial public offering price.
On June 4, 1997, the Company effected a stock split in the form of a stock
dividend in the amount 0.5579 shares for every one share outstanding as of the
effective date of the transaction. All share and per share information in the
accompanying consolidated financial statements have been retroactively adjusted
to give effect to the modification to the Company's capital structure.
F-13
<PAGE>
[Map of world with the locations of the Company's manufacturing and customer
operations identified.]
[Picture of inTEST Test Head Hoist with test head and wafer prober.]
<PAGE>
================================================================================
No dealer, sales representative or any other person has been authorized
to give any information or to make any representations in connection with this
offering other than those contained in this Prospectus and, if given or made,
such information or representations must not be relied upon as having been
authorized by the Company, the Selling Stockholders or any of the Underwriters.
This Prospectus does not constitute an offer to sell or a solicitation of any
offer to buy any security other than the shares of Common Stock offered by this
Prospectus, nor does it constitute an offer to sell or a solicitation of any
offer to buy the shares of Common Stock in any jurisdiction in which such offer
or solicitation is not authorized, or in which the person making such offer or
solicitation is not qualified to do so, or to any person to whom it is unlawful
to make such offer or solicitation. Neither the delivery of this Prospectus nor
any sale made hereunder shall, under any circumstances, create any implication
that the information contained herein is correct as of any time subsequent to
the date hereof.
-----------------------------------
TABLE OF CONTENTS
Page
-----
Prospectus Summary ................................................ 3
Risk Factors ...................................................... 5
The Company ...................................................... 9
Use of Proceeds ................................................... 9
S Corporation Distributions ....................................... 10
Dividend Policy ................................................... 10
Capitalization ................................................... 11
Dilution ......................................................... 12
Selected Consolidated Financial Data .............................. 13
Management's Discussion and Analysis of
Financial Condition and Results of
Operations ...................................................... 14
Business ......................................................... 20
Management ......................................................... 30
Principal and Selling Stockholders ................................. 36
Description of Capital Stock ....................................... 37
Shares Eligible for Future Sale .................................... 38
Underwriting ...................................................... 39
Legal Matters ...................................................... 40
Experts ............................................................ 40
Additional Information ............................................. 40
Index to Consolidated Financial Statements ........................ F-1
-----------------------------------
Until _______, 1997, all dealers effecting transactions in the Common Stock
offered hereby, whether or not participating in this distribution, may be
required to deliver a Prospectus. This is in addition to the obligations of
dealers to deliver a Prospectus when acting as Underwriters and with respect to
their unsold allotments or subscriptions.
================================================================================
================================================================================
2,275,000 Shares
[inTEST Logo]
Common Stock
-------------------
P R O S P E C T U S
-------------------
JANNEY MONTGOMERY SCOTT INC.
NEEDHAM & COMPANY, INC.
____, 1997
================================================================================
<PAGE>
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 13. Other Expenses of Issuance and Distribution
Set forth below is an estimate of the approximate amount of fees and
expenses (other than underwriting commissions and discounts) payable by the
Company in connection with the issuance and distribution of the Common Stock
pursuant to the Prospectus contained in this Registration Statement. The
Company will pay all of these expenses.
<TABLE>
<CAPTION>
Approximate
Amount
------------
<S> <C>
Securities and Exchange Commission registration fee ...... $ 8,324
NASD filing fee .......................................... 3,248
Blue Sky expenses ....................................... 5,000
Nasdaq company listing fee .............................. 32,277
Accountants fees and expenses ........................... 150,000
Legal fees and expenses ................................. 200,000
Transfer Agent and Registrar fees and expenses ............ 7,000
Printing and engraving expenses ........................... 90,000
Directors' and Officers' insurance ........................ 130,000
Miscellaneous expenses .................................... 29,151
--------
Total ................................................ $655,000
========
</TABLE>
Item 14. Indemnification of Directors and Officers
Article VI of the Company's Bylaws provides that the Company shall
indemnify its directors and officers to the fullest extent permitted by the
General Corporation Law of the State of Delaware ("DGCL"). The Bylaws require
the Company, among other things, to indemnify such directors and officers
against certain liabilities that may arise by reason of their status or service
as directors or officers, to advance expenses to them as they are incurred,
provided that they undertake to repay the amount advanced if it is ultimately
determined by a court that they are not entitled to indemnification and to
obtain directors' and officers' liability insurance if available on reasonable
terms. The Bylaws require the Company to indemnify an officer or director in
connection with a proceeding (or part thereof) initiated by such officer or
director only if the initiation of such proceeding was authorized by the Board
of Directors. Reference is made to Section 145 of the DGCL which provides for
indemnification of directors and officers in certain circumstances.
Article IX of the Company's Certificate of Incorporation provides that a
director of the Company shall not be personally liable to the Company or its
stockholders for monetary damages for breach of his or her fiduciary duty as a
director, except for liability (i) for any breach of the director's duty of
loyalty to the Company or its stockholders, (ii) for acts or omissions not in
good faith or which involve intentional misconduct or a knowing violation of
law, (iii) for willful or negligent conduct in paying dividends or repurchasing
stock out of other than lawfully available funds or (iv) for any transaction
from which the director derives an improper personal benefit.
The Company has applied for an insurance policy which will entitle the
Company to be reimbursed for certain indemnity payments it is required or
permitted to make to its directors and officers.
Item 15. Recent Sales of Unregistered Securities
On October 4, 1994, the Company issued 5,000 shares (7,789 shares after
the stock dividend to occur on the effective date of this Registration
Statement (the "Stock Dividend")) of Common Stock to William R. Blatchley in
exchange for services rendered. No underwriters were involved in the issuance
of these securities and no commissions were paid. The shares of Common Stock
were issued in reliance on the exemption from registration contained in Section
4(2) of the Securities Act.
II-1
<PAGE>
On June 1, 1995, the Company issued 10,000 shares (15,579 shares after
giving effect to the Stock Dividend) of Common Stock to Christopher L. West in
exchange for services rendered. No underwriters were involved in the issuance
of these securities and no commissions were paid. The shares of Common Stock
were issued in reliance on the exemption from registration contained in Section
4(2) of the Securities Act.
On June 27, 1995, the Company issued 10,000 shares (15,579 shares after
giving effect to the Stock Dividend) of Common Stock to William R. Blatchley in
exchange for services rendered. No underwriters were involved in the issuance
of these securities and no commissions were paid. The shares of Common Stock
were issued in reliance on the exemption from registration contained in Section
4(2) of the Securities Act.
On June 27, 1995, the Company issued 10,000 shares (15,579 shares after
giving effect to the Stock Dividend) of Common Stock to Jerome R. Bortnam in
exchange for services rendered. No underwriters were involved in the issuance
of these securities and no commissions were paid. The shares of Common Stock
were issued in reliance on the exemption from registration contained in Section
4(2) of the Securities Act.
On June 27, 1995, the Company issued 10,000 shares (15,579 shares after
giving effect to the Stock Dividend) of Common Stock to Jack R. Edmunds in
exchange for services rendered. No underwriters were involved in the issuance
of these securities and no commissions were paid. The shares of Common Stock
were issued in reliance on the exemption from registration contained in Section
4(2) of the Securities Act.
Each of the foregoing recipients of shares was and is an employee of the
Company, and the shares were issued for services rendered in such person's
capacity as an employee. In each instance, the securityholder represented that
such securities were acquired for investment for his own account and not for
distribution. The certificate representing the securities are legended.
II-2
<PAGE>
Item 16. Exhibits
(a) Exhibits.
<TABLE>
<S> <C>
1. **** Form of Underwriting Agreement.
3.1* Certificate of Incorporation of inTEST CORP.
3.2**** Bylaws of inTEST CORP.
4.1**** Specimen stock certificate representing Common Stock.
5. Opinion of Saul, Ewing, Remick & Saul as to the legality of the securities being registered (includ-
ing consent).
10.1* Amended and Restated Loan Agreement, dated June 30, 1996, between inTEST CORP and PNC
Bank, National Association.
10.2* Lease, dated February 11, 1996, between Cherry Hill Industrial Sites, Inc. and inTEST CORP.
10.3* Lease, dated August 5, 1996, between KIP Properties and inTEST CORP.
10.4* Lease, dated December 2, 1977, between Alan Breck Robertson and Mavis Robertson and Robertson
Engineering (Thame) Limited ("U.K. Lease").
10.5* Assignment of U.K. Lease, dated January 28, 1986, between Citycrown Engineering Limited and
inTEST LTD.
10.6* Tenancy Agreement, dated April 18, 1996, between Alambon Tools Private Limited and inTEST PTE.
10.7* Agreement of Exchange between Alyn R. Holt and inTEST CORP, dated April 4, 1997. Each of the
minority stockholders of inTEST LTD, inTEST PTE and inTEST KK have executed Agreements of
Exchange which are substantially identical to Mr. Holt's except as to certain requirements under the
laws of each foreign jurisdiction and also as to the parties, the number of shares exchanged and the
number of inTEST CORP shares received as set forth below:
</TABLE>
<TABLE>
<CAPTION>
Number of Shares Number of Shares
Party Pre-Exchange Post-Exchange**
----- ------------------ -----------------
<S> <C> <C> <C> <C>
inTEST LTD: Alyn R. Holt 2,775 37,237
Brian R. Moore 6,947 93,219
Julian P. Partington 3,403 45,664
inTEST PTE: Alyn R. Holt 16,500 11,250
Cornelis Hol 15,000 10,228
inTEST KK: Micronics Japan Company, Ltd. 60 48,209
Tomoyasu Ogura 54 43,388
Cornelis Hol 6 4,820
Tomio Wakamatsu 4 3,214
Kenji Murayama 4 3,214
</TABLE>
<TABLE>
<S> <C>
10.8 * 1997 Stock Plan.
10.10*** Consulting Agreement, dated April 1, 1997, between inTEST CORP and Stuart F. Daniels, Ph.D.
21. * Subsidiaries of the Company.
23.1 Consent of KPMG Peat Marwick LLP.
23.2 Consent of Saul, Ewing, Remick & Saul (contained in its opinion filed as Exhibit 5 hereto).
23.3 Consent of Ratner & Prestia.
24* Power of Attorney (see signature page).
27.1 * Financial Data Schedule for the year ended December 31, 1996.
27.2 * Financial Data Schedule for the quarter ended March 31, 1997.
</TABLE>
- ------------
* Previously filed as an exhibit to the Company's Registration Statement
filed on May 2, 1997.
** Adjusted to reflect stock dividend paid as of June 4, 1997.
*** Previously filed as an exhibit to Amendment No. 1 filed on May 13, 1997.
**** Previously filed as an exhibit to Amendment No. 2 filed on June 6, 1997.
(b) Financial Statement Schedules
Schedule II -- Valuation of Qualifying Accounts.
All other schedules for which provision is made in the applicable
accounting regulations of the Securities and Exchange Commission are not
required under the related instructions or are inapplicable, and therefore have
been omitted.
II-3
<PAGE>
Item 17. Undertakings
The Registrant hereby undertakes:
(1) To provide to the Underwriters at the closing specified in the
Underwriting Agreement, certificates in such denominations and registered in
such names as required by the Underwriters to permit prompt delivery to each
purchaser.
(2) Insofar as indemnification for liabilities arising under the
Securities Act may be permitted to directors, officers and controlling persons
of the Company pursuant to the applicable provisions of the DGCL, or otherwise,
the Company has been advised that in the opinion of the Commission, such
indemnification is against public policy as expressed in the Securities Act and
is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the Company of expenses
incurred or paid by a director, officer or controlling person of the Company in
the successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the Company will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.
(3) For purposes of determining any liability under the Securities Act,
the information omitted from the form of prospectus filed as part of this
Registration Statement in reliance upon Rule 430A and contained in a form of
prospectus filed by the Company pursuant to Rule 424(b)(1) or (4) or 497(h)
under the Securities Act shall be deemed to be part of this Registration
Statement as of the time it was declared effective.
(4) For the purpose of determining any liability under the Securities Act,
each post-effective amendment that contains a form of prospectus shall be
deemed to be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.
II-4
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Act, the Registrant has
duly caused this Amendment No. 3 to the Registration Statement to be signed on
its behalf by the undersigned, thereunto duly authorized, in the Township of
Cherry Hill, and State of New Jersey on the 16th day of June, 1997.
inTEST CORPORATION
By: /s/ Alyn R. Holt
------------------------------------
Alyn R. Holt
Chairman and Chief Executive Officer
Pursuant to the requirements of the Securities Act, this Amendment No. 3
to the Registration Statement has been signed below by the following persons in
the capacities indicated on June 16, 1997.
<TABLE>
<CAPTION>
Signature Title
--------- -----
<S> <C>
/s/ Alyn R. Holt Chairman and Chief Executive Officer
- ----------------------------------- (principal executive officer)
Alyn R. Holt
*
- ----------------------------------- President, Chief Operating Officer and Director
Robert E. Matthiessen
*
- ----------------------------------- Senior Vice President and Director
Daniel J. Graham
* Chief Financial Officer and Treasurer
- ----------------------------------- (principal financial officer and accounting
Hugh T. Regan, Jr. officer)
* Secretary
- -----------------------------------
Hugh T. Regan, Sr.
* Director
- -----------------------------------
Richard O. Endres
* Director
- -----------------------------------
Stuart F. Daniels
/s/ Alyn R. Holt
* By:-------------------------------
Alyn R. Holt
Attorney-in-Fact
</TABLE>
II-5
<PAGE>
inTEST CORPORATION AND SUBSIDIARIES
Schedule II
Valuation and Qualifying Accounts
(in thousands)
<TABLE>
<CAPTION>
Additions
------------------------------
Balance at Charged to
For the year ended beginning costs and Charged to other Balance at
December 31, of period expenses accounts-describe Deductions end of period
- ----------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C>
1994 Allowance for doubtful accounts $ 31 $50 $ -- $28 $53
1995 53 18 -- 29 42
1996 42 50 -- 4 88
- ----------------------------------------------------------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------------------------------
1994 Warranty reserve $ -- $-- $ -- $-- $--
1995 -- -- -- -- --
1996 -- 25 -- -- 25
- ----------------------------------------------------------------------------------------------------------------------------------
</TABLE>
S-1
<PAGE>
Exhibit Index
<TABLE>
<CAPTION>
Exhibit
Number Title or Description
- ------ --------------------
<S> <C>
5. Opinion of Saul, Ewing, Remick & Saul.
23.1 Consent of KPMG Peat Marwick LLP.
23.2 Consent of Saul, Ewing, Remick & Saul (contained in its opinion filed as Exhibit 5 hereto).
23.3 Consent of Ratner & Prestia.
</TABLE>
<PAGE>
Exhibit 5
<TABLE>
<CAPTION>
LAW OFFICES OF
SAUL, EWING, REMICK & SAUL
<S> <C> <C>
BERWYN, PENNSYLVANIA 3800 CENTRE SQUARE WEST PRINCETON, NEW JERSEY
HARRISBURG, PENNSYLVANIA PHILADELPHIA, PA 19102 WILMINGTON, DELAWARE
NEW YORK, NEW YORK
(215) 972-7777
Fax: (215) 972-7725
Internet Email: [email protected]
World Wide Web: http://www.saul.com
</TABLE>
June 16, 1997
inTEST Corporation
2 Pin Oak Lane
Cherry Hill, NJ 08003
Re: inTEST Corporation
Registration Statement on Form S-1
Ladies and Gentlemen:
We have acted as counsel to inTEST Corporation, a Delaware corporation
(the "Company"), in connection with the preparation of a Registration Statement
on Form S-1, as amended (the "Registration Statement"), filed with the
Securities and Exchange Commission under the Securities Act of 1933, as amended
(the "Act"), relating to the public offering of up to 2,275,000 shares of the
Company's common stock, par value $0.01 per share (the "Common Stock"), of which
1,820,000 shares of authorized but heretofore unissued shares of Common Stock
will be sold by the Company and 455,000 shares of Common Stock will be sold
severally by the selling stockholders named in the Registration Statement (the
"Selling Stockholders").
We have assumed for the purposes of this opinion that an Underwriting
Agreement substantially in the form of that filed as Exhibit 1 to the
Registration Statement (the "Underwriting Agreement") has been duly executed and
delivered by the Company, the Selling Stockholders and Janney Montgomery Scott,
Inc. and Needham & Company, Inc. as representatives of the several underwriters
named therein (the "Underwriters"). The Registration Statement also relates to
341,250 shares of Common Stock that may be sold by the Selling Stockholders
pursuant to the Underwriters' over-allotment option pursuant to the terms of the
Underwriting Agreement. We have also assumed for the purposes of this opinion
that the 300,443 shares of Common Stock to be issued in exchange for the
minority interests of the Company's three foreign subsidiaries has taken place
as contemplated by the Registration Statement.
We have reviewed (a) the Registration Statement; (b) the Company's
Certificate of Incorporation and Bylaws; (c) certain records of the Company's
corporate proceedings as reflected in its minute and stock books; and (d) such
other documents and instruments as we have deemed necessary or appropriate for
purposes of this opinion. In our examination, we have assumed the genuineness of
all signatures, the authenticity of all documents submitted to us as originals
and the conformity with the original of all documents submitted to us as copies
thereof.
<PAGE>
Our opinion set forth below is limited to the General Corporation Law
of the State of Delaware.
We are of the opinion that:
1. The shares of Common Stock to be issued by the Company to the
Underwriters as described in the Registration Statement, when
and to the extent purchased by the Underwriters in accordance
with the Underwriting Agreement, will be legally issued, fully
paid and non-assessable; and
2. The shares of Common Stock to be sold by the Selling
Stockholders to the Underwriters as described in the
Registration Statement have been legally issued and are fully
paid and non-assessable.
We hereby consent to the use of this opinion as Exhibit 5 to the
Registration Statement. In giving such opinion, we do not thereby admit that we
are acting within the category of persons whose consent is required under
Section 7 of the Act or the rules or regulations of the Securities and Exchange
Commission thereunder.
Very truly yours,
/s/ Saul, Ewing, Remick & Saul
<PAGE>
Exhibit 23.1
Consent of Independent Certified Public Accountants
The Board of Directors
inTEST Corporation:
The audits referred to in our report dated March 14, 1997, included the related
financial statement schedule for each of the years in the three-year period
ended December 31, 1996, included in the registration statement. This financial
statement schedule is the responsibility of the Company's management. Our
responsibility is to express an opinion on this financial statement schedule
based on our audits. In our opinion, the financial statement schedule, when
considered in relation to the basic consolidated financial statements taken as a
whole, presents fairly, in all material respects, the information set forth
therein.
We consent to the use of our reports included herein and to the references to
our firm under the headings "Selected Consolidated Financial Data" and "Experts"
in the prospectus.
/s/ KPMG Peat Marwick LLP
- -------------------------
Philadelphia, Pennsylvania
June 13, 1997
<PAGE>
Exhibit 23.3
CONSENT OF RATNER & PRESTIA
We hereby consent to the reference to our firm under the headings "Legal
Matters" and "Experts" in this Registration Statement and the related Prospectus
of inTEST Corporation.
RATNER & PRESTIA
/s/ Allan Ratner
------------------
Allan Ratner
Berwyn, PA
June 13, 1997
